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Summary of the major research project 
 
Section A 
This systematic literature review analysed twenty-three qualitative and quantitative studies 
investigating the experiences of illness uncertainty in the lives of people living with HIV. 
Specifically, the review aimed to identify sources of illness uncertainty for this population and the 
ways in which people living with HIV manage these uncertainties. These results were discussed 
within the frame of current theory and further areas of research were identified. 
 
Section B 
This is a cross-sectional online survey investigating the relationships between self-report measures 
of social environment (i.e. social support and experiences of discrimination), illness uncertainty 
and quality of life in an opportunity sample of people living with HIV. In line with theory, 
discrimination and social support were found to be differentially related to illness uncertainty. 
Furthermore, illness uncertainty was found to be related to quality of life. Clinical and theoretical 
implications as well as limitations to the study and future research were discussed. 
 
Section C 










Table of Contents 
Sections A: Illness uncertainty in the lives of people living with HIV: A review 
List of Figures ................................................................................................................................ ix 
Section A: Literature Review ......................................................................................................... ix 
Abstract ....................................................................................................................................... - 1 - 
Introduction ................................................................................................................................. - 2 - 
People Living with HIV .......................................................................................................... - 2 - 
Uncertainty in Health Care ..................................................................................................... - 4 - 
Uncertainty in Illness Theory. ............................................................................................ - 4 - 
Managing Illness Uncertainty. ............................................................................................ - 6 - 
Illness Related Uncertainty in Chronic Illnesses ................................................................ - 7 - 
Summary and Rationale .......................................................................................................... - 8 - 
Aims ........................................................................................................................................ - 9 - 
Method ........................................................................................................................................ - 9 - 
Literature Search ..................................................................................................................... - 9 - 
Inclusion Criteria .................................................................................................................... - 9 - 
Study Selection ..................................................................................................................... - 10 - 
Quality Assessment ............................................................................................................... - 11 - 
Literature Synthesis .............................................................................................................. - 12 - 
Review ...................................................................................................................................... - 12 - 
 v 
 
Sampling ............................................................................................................................... - 12 - 
Design Characteristics .......................................................................................................... - 13 - 
Thematic Account of Qualitative Research .......................................................................... - 14 - 
Sources of Uncertainty ...................................................................................................... - 16 - 
Medical Sources of Uncertainty. ................................................................................ - 16 - 
Making Sense of Symptoms. ................................................................................... - 16 - 
Disease Progression. ................................................................................................ - 16 - 
Health Care Systems and Competing Sources of Knowledge. ............................... - 17 - 
Personal Sources of Uncertainty Related to HIV. ...................................................... - 18 - 
HIV-stigma and Uncertainty Related to Disclosure. .................................................. - 19 - 
Managing HIV-related Uncertainty .................................................................................. - 20 - 
Seeking Information. .................................................................................................. - 20 - 
Avoiding Information. ................................................................................................ - 21 - 
Accepting Uncertainty and Becoming Hopeful. ......................................................... - 22 - 
Social Support. ............................................................................................................ - 23 - 
Synthesis of Quantitative Research ...................................................................................... - 24 - 
Discussion ................................................................................................................................. - 26 - 
Structural Providers .............................................................................................................. - 26 - 
Stimuli Frame ........................................................................................................................ - 28 - 
Cognitive Capacity ................................................................................................................ - 28 - 
 vi 
 
Appraisal of Illness Uncertainty and Coping ........................................................................ - 29 - 
Limitations of the Studies ..................................................................................................... - 29 - 
Research Implications ........................................................................................................... - 31 - 
Conclusions ........................................................................................................................... - 32 - 
References ................................................................................................................................. - 33 - 
Section B: The social environment, illness related uncertainty and quality 
of life of people living with HIV 
Abstract ..................................................................................................................................... - 43 - 
Introduction ............................................................................................................................... - 45 - 
Living with HIV-related Uncertainty .................................................................................... - 45 - 
Social Context and Illness Uncertainty ................................................................................. - 47 - 
Intersectional Stigma and HIV-related Uncertainty ......................................................... - 47 - 
Study Aims and Hypothesis .................................................................................................. - 49 - 
Methods..................................................................................................................................... - 51 - 
Design ................................................................................................................................... - 51 - 
Procedure .............................................................................................................................. - 51 - 
Participants ............................................................................................................................ - 52 - 
Measures ............................................................................................................................... - 52 - 
Demographic Data ............................................................................................................ - 52 - 
Illness Uncertainty ............................................................................................................ - 52 - 
 vii 
 
Perceived Social Support .................................................................................................. - 53 - 
Quality of Life .................................................................................................................. - 54 - 
Experiences of Discrimination .......................................................................................... - 54 - 
Data Analysis ........................................................................................................................ - 55 - 
Statistical Power and Sample Size .................................................................................... - 57 - 
Results ....................................................................................................................................... - 58 - 
Demographics ....................................................................................................................... - 58 - 
Descriptive Statistics ............................................................................................................. - 60 - 
Hypothesis Testing ................................................................................................................ - 65 - 
Hierarchical Multiple Regression on Illness Uncertainty ................................................. - 65 - 
H. 1 High levels of social support are associated to lower levels of illness uncertainty. .. - 
66 - 
H. 2 Experiencing multiple forms of discrimination is associated to higher levels of illness 
uncertainty. .................................................................................................................... - 66 - 
H. 3 Frequency of discrimination experiences are associated to higher levels of illness 
uncertainty. .................................................................................................................... - 66 - 
Characteristics Attributed to Experiences of Discrimination. ................................. - 69 - 
Multiple Regression on Quality of Life ............................................................................ - 70 - 
H. 4 Lower levels of illness uncertainty are associated to higher levels of reported quality 
of life. ............................................................................................................................ - 71 - 
Discussion ................................................................................................................................. - 73 - 
 viii 
 
Main Findings ....................................................................................................................... - 73 - 
Strengths and Limitations ..................................................................................................... - 75 - 
Future Research .................................................................................................................... - 77 - 
Clinical Implications ............................................................................................................. - 77 - 
Conclusions ........................................................................................................................... - 79 - 
References ................................................................................................................................. - 80 - 
Section C: Appendices 
Appendix A. Terms adopted in systematic search ................................................................ - 94 - 
Appendix B. Summary of quality assessment: qualitative studies ....................................... - 95 - 
Appendix C. Summary of quality assessment: quantitative studies ..................................... - 97 - 
Appendix D. Summary of studies included in the review .................................................... - 99 - 
Appendix E. Thematic table with selection of participant’s quotes ................................... - 111 - 
Appendix F. Patient information sheet ............................................................................... - 116 - 
Appendix G. Patient consent form ...................................................................................... - 120 - 
Appendix H. Demographic items and constructs ............................................................... - 122 - 
Appendix I. Ethics board approval ..................................................................................... - 123 - 
Appendix J. Bar chart of means scores of predictors and outcomes by country showing 95% 
confidence intervals ............................................................................................................ - 124 - 
Appendix K. Scatter plot of standardized residual against standardised predicted value for the 
regression on illness uncertainty (model 4) ........................................................................ - 125 - 
 ix 
 
Appendix L. Scatter plot of standardized residual against standardised predicted value for the 
regression on quality of life ................................................................................................ - 126 - 
Appendix M. Social media advertisement .......................................................................... - 127 - 
Appendix N. Resources for participants in distress ............................................................ - 128 - 
Appendix O. End of study summary sent to the Salomons Ethics Committee ................... - 131 - 
  
 
List of Tables 
Section A: Literature Review 
Table 1. Core themes and sub-themes ...................................................................................... - 15 - 
Section B: Empirical Study 
Table 1. Participant demographics . .......................................................................................... - 58 - 
Table 2. Comparison of UK sample characteristics with UK National Statistics. ................... - 60 - 
Table 3.  Descriptive statistics of measures .............................................................................. - 63 - 
Table 4. Bivariate correlations of variables .............................................................................. - 64 - 
Table 5. Results of hierarchical linear regression model predicting illness uncertainty. ......... - 68 - 
Table 6. EDS count of attributed characteristics by ethnicity  ................................................. - 69 - 
Table 7. Results of linear regression model predicting quality of life ...................................... - 70 - 
 
List of Figures 
Section A: Literature Review 
Figure 1. Model of perceived uncertainty in illness (adapted from Mishel, (1988) ................... - 5 - 
 x 
 
Figure 2. Flowchart illustrating systematic search process ...................................................... - 11 - 
Section B: Empirical Study 
Figure 1. Scatterplot of MUIS-C scores across time (days) ..................................................... - 62 - 


















Illness uncertainty in the lives of people living with HIV: A review. 
 




















SALOMONS INSTITUTE  





 - 1 - 
Abstract 
Background and objectives: People living with HIV face a broad range of complex decisions 
related to the illness, and as a consequence experience uncertainty. Evidence and theory suggest 
that uncertainty related to illness can have a significant impact on the experiences and outcomes 
of people living with a variety of chronic conditions. The aim of this review was to provide a 
synthesis of the empirical evidence illustrating the way in which illness uncertainty impacts the 
lives of people living with HIV.  
Methodology: A systematic literature review was conducted to identify qualitative and quantitative 
literature. A sequential exploratory synthesis was employed in analysing the studies. 
Results: Eighteen qualitative studies and five quantitative studies were identified. The major 
sources of uncertainty identified were: medical aspects of the condition, the consequences of the 
illness on the person’s professional, financial and relational contexts, and living with a highly 
stigmatised condition. PLWHIV reported managing these uncertainties through the interplay of 
seeking information and avoidance strategies while also relying on different structures of social 
support. Some participants in the studies also described a process of adaptation to uncertainty 
which in some cases allowed them to stay hopeful for the future.  
Conclusions: People living with HIV experience a broad range of uncertainties related to living 
with the condition. Qualitative analysis identified themes reflecting theory as well as aspects of 
uncertainty specific to living with HIV. Quantitative literature replicated findings in populations 
of individuals with different chronic conditions and converged with qualitative findings as well as 
theory. Limitations of the studies reviewed and areas of further research are discussed. 
 
Keywords: HIV, illness uncertainty, chronic conditions  
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Introduction 
People Living with HIV 
The Human Immunodeficiency Virus (HIV) was first isolated in 1983. The virus attacks the body’s 
immune system and it can lead to life threatening opportunistic infections and specific types of 
cancers if diagnosed late and/or not treated with medications. At the end of 2019 there were an 
estimated 38 million people worldwide living with HIV (World Health Organization, 2020) of 
which over one-hundred-thousand lived in the United Kingdom (National AIDS Trust UK, 2020). 
At the beginning of the HIV pandemic the majority of people becoming infected with the virus 
developed fatal illnesses with a shortened lifespan. A decade later the introduction of highly active 
antiretroviral therapies (HAART)  had a major impact on the prognosis for people diagnosed with 
the condition in higher-income countries (Palella et al., 1998) and later for people in lower-income 
countries (Ford et al., 2011). Over the years these changes in treatment led to radical improvements 
in life expectancy and quality of life (May, Ingle, et al., 2014). The life-threatening implications 
of the condition were greatly reduced and the term ‘People Living With HIV’ (PLWHIV) came 
into use to reflect the management of the disease as a chronic condition. However, in spite of these 
improvements, the condition remains difficult to manage for many PLWHIV. PLWHIV face 
complex illness-related challenges such as having to manage health conditions that pre-existed 
HIV infection or developed as a consequence of it (United States Department of Health and Human 
Services, 2019). Managing the condition can be complex and can entail: taking decisions about 
treatment while considering medication side-effects (Kremer et al., 2006); managing HIV-
diagnosis disclosure in order to protect oneself and loved ones from stigma (Greeff, 2013); 
managing intimacy while negotiating protective sexual practices (Leblanc et al., 2017); and 
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planning a family while considering the risks of vertical transmission (Bravo et al., 2010). These 
are but some of the many challenges with which PLWHIV must contend.  
It is unsurprising then, that reports of uncertainty related to managing the illness are 
prevalent in the experience of PLWHIV (Brashers et al., 2009), as exemplified in the many 
challenges and decisional dilemmas they have to confront. Systematic reviews of the literature 
have gathered ample evidence indicating that uncertainty in illness is linked to the mental health 
and physical wellbeing of individuals with chronic conditions (Neville, 2003; Zhang, 2017). This 
is particularly important for PLWHIV, as compared to the general population they are more likely 
to experience mental health problems (National AIDS Trust UK, 2018). Minoritiesed1 groups 
identified by ethnicity, gender, sexuality and social status experience higher risks of developing 
mental health issues, while also experiencing higher risks of contracting the virus (Public Health 
England, 2018).  This is because both HIV-infection and mental health share many of the same 
risk factors including socioeconomic deprivation, stigma and isolation (Brezing et al., 2015).  
In summary, while the last few decades have seen considerable improvement in the treatment 
and prognosis of HIV, people living with the condition still face many illness-related challenges 
which can lead to experiences of uncertainty (Bravo et al., 2010). Evidence has surfaced showing 
that uncertainty in illness is related to both mental health and physical outcomes of people living 
with chronic conditions. The following sections will be outlining the development of the 
conceptualisations of ‘illness uncertainty’ (IU) in the context of health and will discuss the 
rationale of this review as well as its aims. 
 
1 The term ‘minoritised’ was drawn from Selvarajah et al. (2020) 
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Uncertainty in Health Care 
As a theoretical construct, uncertainty extends across a wide range of theoretical domains and 
professions. To date, there is no readily identifiable body of literature that unifies the concept of 
uncertainty (Kasperson, 2008). Different authors have presented reviews of the concept of 
uncertainty within medical and illness contexts (Han et al., 2011). One of the most influential and 
referenced theories of uncertainty in illness was proposed by Mishel (1988, 1990). 
Uncertainty in Illness Theory. Uncertainty in Illness Theory (UIT) was first proposed by Mishel 
(1988) to explain the processes involved in adaptation to acute illness. It proposes that when 
individuals are unable to form cognitive schemas of their illness experiences, this leads to “the 
inability to determine the meaning of illness-related events [that] occur in situations where the 
decision-maker is unable to assign definite values to objects and events and/or is unable to 
accurately predict outcomes because sufficient cues are lacking” (Mishel, 1988, p.225).  
According to this model individuals structure a cognitive schema of their illness experience 
through the ‘stimuli frame’(see Figure 1). The stimuli frame is the degree to which the course of 
the illness follows a pattern and is familiar and congruent with an individual’s expectations. In this 
model two variables can support the stimuli frame: the cognitive capacity of the individual and 
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Figure 1 
Model of perceived uncertainty in illness (adapted from Mishel, (1988) 
 
 
Cognitive capacity is understood as the information processing ability of an individual.  
Reduced capacity to process information due to medication, for instance, is postulated to have a 
deleterious effect on the ability to process the stimuli frame. Structure providers are constituted by 
the social resources the individual has at their disposal. Health care providers for instance, can 
function as credible authority and providers of expertise and education. Friends and family can 
also assist in the interpretation of the stimuli frame. Structure providers can help form a cognitive 
schema of illness events and also provide resources that directly reduce illness related uncertainty.  
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Based on these premises, the theory proposes that barriers to the development of a cognitive 
schema are constituted by illness stimuli that have poor patterns, are unfamiliar and incongruent. 
Ineffective support from structure providers and poor cognition will also lead to uncertainty. 
 Drawing from Lazarus and Folkman (1984), Mishel proposed that uncertainty is neither 
inherently good nor bad, and  can be appraised by individuals as danger or opportunity. For 
example, PLWHIV may perceive uncertainty about the efficacy of medication as a threat, while 
perceiving uncertainty about long-term prognosis as opportunity because it can help promote 
change with optimism (Brashers et al., 2000). Mishel (1990) later expanded her model of UIT in 
order for it to also explain experiences of uncertainty in chronic conditions.  In this later version 
of the model the final stage of ‘adaptation’ was conceptualised as a new sense of order where 
uncertainty becomes an accepted and integral part of a person’s life. In this version of UIT 
individuals experience a shift towards probabilistic thinking, in which the expectation of certainty 
and predictability is abandoned. This is in contrast to a previous understanding of adaptation that 
saw the individual return to pre-illness psychological, behavioural and social functioning.  
Managing Illness Uncertainty. Illness Uncertainty Theory distinguishes itself from other 
conceptualisations of uncertainty which see individuals as inherently motivated to reduce 
uncertainty through a variety of information seeking strategies (Berger and Calabrese, 1975; 
Selder, 1989). Over the years empirical evidence has grown in support of an understanding of 
uncertainty as not inherently threatening but rather, potentially related to a variety management 
strategies  that are aimed at both uncertainty reduction and promotion (Kuang and Wilson, 2017). 
A meta-analysis by Kuang and Wilson (2017) has evidenced three main strategies in the 
management of IU. These are:  1) seeking information, 2) avoiding information and 3) cognitive 
reappraisal of illness related uncertainty. 
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 Seeking additional information can have the effect of both increasing or decreasing 
uncertainty. If uncertainty is appraised as opportunity because the individual has negative beliefs 
concerning illness prognosis, searching for additional contradictory evidence can increase 
uncertainty by introducing an alternative perspective (Frey et al., 1996). Alternatively, an 
individual may search additional information regarding symptoms they have experienced, in order 
to ascertain the cause of the symptoms and reduce uncertainty (Mishel, 1990). 
 If uncertainty is appraised as threat this may lead the individual to avoidant coping (Lazarus 
and Folkman, 1984). Avoidance can protect people from confusing and distressing knowledge and 
provide relief from a distressing certainty. Avoidant coping can include: distracting oneself from 
illness related stimuli, avoiding thinking about the illness, denying that the situation is problematic, 
disengaging from treatment and other illness related contexts, and avoiding any media or social 
situation that reminds the person of the illness (Brashers et al., 2000; Ratneshwar et al., 1997) 
Finally, individuals also manage uncertainty by engaging in the cognitive reappraisal of IU where 
the individual is able to develop a new sense of order about their illness experience. According to 
Mishel (1990) this is achieved through a dynamic process where the experience of chronic IU is 
integrated in the cognitive representation of the self and the world. 
Illness Related Uncertainty in Chronic Illnesses 
Empirically, IU has been investigated within a wide range of chronic conditions and has been 
shown to be related to a broad variety of outcomes. Wright, Afari, and Zautra (2009) conducted a 
review of quantitative and qualitative studies investigating the effects of IU in several chronic 
conditions. They concluded that IU influences adaptation to illness and can alter the experience of 
perceived acute pain in a variety of conditions. Of note is  a longitudinal study by Reich, Johnson, 
Zautra, and Davis (2006) who carried out a study with patients living with fibromyalgia. They 
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were able to show that IU was positively associated with anxiety, negative affect and avoidant and 
passive coping. There is much cross-sectional evidence across types of chronic conditions 
suggesting negative associations between IU and coping and quality of life (Lynch et al., 2001; 
Schneider, 2000; Wonghongkul et al., 2006a).  Pertinent to PLWHIV is also evidence in paediatric 
transplant patients  suggesting there may be a link between IU and treatment adherence (Maikranz, 
Steele, Dreyer, Stratman, and Bovaird, 2006). A longitudinal study by Hoth et al. (2013) with 400 
participants suffering Chronic Obstructive  Pulmonary Disease (COPD), was able to demonstrate 
that uncertainty around experienced physical symptoms predicted clinical outcomes over a two 
year period. Furthermore, a series of interventions targeting IU have shown their effectiveness in 
improving clinical symptoms, self-efficacy and  life satisfaction, in addition to lowering pain 
(Bailey et al., 2004; Gil et al., 2006; Jiang and He, 2012; LeFort, 2000; Mishel et al., 2002). 
Summary and Rationale 
Because PLWHIV face a broad variety of complex decisions related to the illness, they often 
have to manage the uncertainties inherent in their condition. There is considerable evidence in line 
with Illness Uncertainty Theory that suggests that uncertainty related to illness can have a 
significant impact on the experiences and outcomes of people living with a variety of chronic 
conditions. Both qualitative and quantitative studies have brought forward evidence of the impact 
uncertainty can have on quality of life, coping abilities and illness progression. Despite the 
documented impact of IU on a variety of chronic conditions, to date there is no study that has 
reviewed the role of IU in the lives of PLWHIV and how it may be related to specific aspects of 
living with the condition. 
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Aims 
The aim of this paper was to review studies that have investigated the role of IU in the lives 
of PLWHIV and to provide a synthesis of the empirical evidence illustrating the ways in which it 
impacts their lives. The research questions that guided this review were: 1) what are the 
experiences of IU reported by PLWHIV? 2) how do PLWHIV manage these uncertainties? Both 
quantitative and qualitative studies were included in this review in order to provide a breadth of 
empirical evidence representative of the areas of research covered since the advent of the HIV 
epidemic from its beginning in the 1980s. This evidence will be considered in the light of current 
theories of IU with the objective of discussing implications for future research. 
Method 
Literature Search 
The literature search was carried out in compliance with PRISMA guidelines (Moher et al., 2009).  
An electronic title search was conducted in December 2019 with the aid of the following database 
systems: Medline, PsychINFO, ASSIA, and CINAHL. A combination of search terms was adopted 
using the ‘AND’ function (e.g. ‘HIV’ AND ‘Uncertainty). Synonyms were included in searches 
using the ‘OR’ function (e.g. ‘Uncertainty’ OR ‘Ambiguity’). The asterisk function was also used 
to ensure that variations of the same search-term would be included in search results (e.g. Uncert*). 
A complete list of combination search-terms used in the literature search is available in appendix 
A. No time limit was applied to the search as the results reflected the historical advent of 
HIV/AIDS in academic research. 
Inclusion Criteria 
Studies were included in the review if: 
- Participant population samples consisted of PLWHIV of any age; 
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- ‘Uncertainty’ or ‘Ambiguity’ in illness were themes that emerged during qualitative study; 
- ‘Uncertainty’ or ‘Ambiguity’ in illness were constructs integrated in the design of a 
quantitative study;  
- The ‘Uncertainty’ or ‘Ambiguity’ in illness under study was that experienced by PLWHIV; 
- They were published in a peer reviewed journal; 
- They were published in English; 
Study Selection 
Initial search results were checked for duplicates. A title screen and abstract screen were carried 
out based on the inclusion criteria. A selection of papers meeting the selection criteria was made 
after reading the full texts. The bibliographies of the articles selected were hand searched to 
identify further articles that met the review criteria. This process yielded twenty-three studies.  An 
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Figure 2 
Flowchart illustrating systematic search process 
 
Quality Assessment 
A quality assessment tool from Kmet et al. (2004) was adopted to aid the critical appraisal 
of the selected studies because it allows for the concurrent evaluation of both  qualitative and 
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in appendices B and C. All studies selected through the search scored above the 75% cut-off and 
were included in the review. 
Literature Synthesis 
Pluye and Hong (2014) propose taking a sequential exploratory synthesis in mixed methods 
reviews in order to facilitate the emergence of gaps in the literature. This type of synthesis consists 
of an initial stage where qualitative studies are analysed with a qualitative method (e.g. thematic 
analysis) and a subsequent stage where quantitative studies are synthesised through quantitative 
methodology (e.g. meta-analysis). This allows for emergent themes in qualitative literature to be 
compared with areas explored quantitatively, thereby allowing for the identification of gaps in the 
literature and the creation of new hypotheses. 
After more than 20 years of theory development in illness related uncertainty for chronic 
conditions, a hybrid deductive-inductive thematic analysis was adopted to synthesise qualitative 
data (Fereday and Muir-Cochrane, 2006). A meta-analysis of the quantitative data was not possible 
due to the small number of quantitative studies returned from the search.  
Review 
A comprehensive table summarizing the studies included in the review can be found in   
appendix D.  
Sampling 
The majority of the studies took place in North America (USA n=11; Canada n=3) and the 
UK (n=6). One study took place in Tanzania, one across Serbia and Montenegro and one in Iran. 
This means that, with the exception of these three studies, experiences of uncertainty related to 
living with HIV in other than British and north-American cultural contexts were largely 
unaccounted for.  
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The majority of participants were recruited in HIV specialist clinics, and various HIV 
advocacy and peer support groups. Only one study used online recruiting (Frain et al., 2008). The 
large majority of sampling was purposive with participant self-selection. This is possibly creates 
sampling bias, especially when considering the evidence for avoidant coping being related to 
experiences of IU (Mishel, 1990). 
The participant population from the selected studies tended to be predominantly gay, male, 
of white ethnicity and living in urbanised areas. Nevertheless, women, ethnic and other sexual 
orientations were present in the samples and are likely to have brought differing accounts to the 
qualitative studies reported here. However, no trans PLWHIV appear to have participated in the 
selected studies, a population that is often neglected or not reached. 
The majority of PLWHIV that participated to the selected studies were of adult age and four 
studies sampled participants over the age of fifty.  Only one study reported the experiences of 
children living with the condition.  
Of the studies, only one was based on interviews that had taken place prior to the introduction 
of HAART in the late 1990s. This is important to consider as the introduction of HAART impacted 
on the level of threat that the condition posed to PLWHIV across the four decades of the pandemic, 
thereby creating at least two cohorts of PLWHIV i.e. those diagnosed prior to the introduction of 
HAART and those diagnosed after.  
The studies selected yielded a mix of participants at advanced stages of the condition and 
participants who were asymptomatic with variance in the time since diagnosis.  
Design Characteristics 
The majority of the studies selected were qualitative (n=18), followed by five quantitative. 
Of these studies only three were prospective (Brashers et al., 2017; Shannon and Lee, 2008; Rose 
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Weitz, 1991), with the majority being cross-sectional designs. While qualitative cross-sectional 
accounts can allow for participants to express retrospective accounts of their experiences of 
change, generally these designs are unlikely to capture the extent of the processes involved in 
change. This means that it was difficult to gather information on how IU for study participants 
changed across time and what factors may have impacted that change. Furthermore, quantitative 
cross-sectional designs do not allow for inferences of the direction of any relationship and are often 
susceptible to third variable effects i.e. the effect of a confounding variable that has not been 
accounted for. 
Two quantitative studies were prospective and allowed some inference of the direction of 
the relationships being investigated (Brashers et al., 2017; Shannon and Lee, 2008). 
Of the five quantitative designs selected, four adopted the Mishel (1981) Illness Uncertainty 
Scale which has been widely used and is a well validated measure. One study used the Parent 
Perception of Uncertainty Scale which measures a parent’s uncertainty of the child’s HIV illness 
(Shannon and Lee, 2008).  In all cases acceptable Cronbach’s Alpha scores were reported.  
Of the quantitative studies selected, grounded theory was the most common methodology 
employed in analysing the data (n=9) followed by thematic analysis (n=7). 
Thematic Account of Qualitative Research 
This section of the review is structured according to the core themes and sub-themes that emerged 
through the thematic analysis.  Table 1 summarizes themes and sub-themes identified. A thematic 
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Sources of Uncertainty 
Similarly to a review carried out by Brashers et al. (2003), three main sources of uncertainty were 
identified in the reports of PLWHIV: 1) medical sources of uncertainty, 2) personal sources of 
uncertainty and 3) social sources of uncertainty related to HIV-disclosure and stigma. 
Medical Sources of Uncertainty.  
Making Sense of Symptoms. Participants in different studies reported at times 
experiencing uncertainty in discerning the causes of the physical ailments they experienced, 
especially if these were unfamiliar (Yarbrough et al., 2001).  
In general, many PLWHIV reported feeling unsettled by the unpredictability of the fluctuation in 
their symptoms and found it difficult to discern whether the symptoms they were experiencing 
were due to their HIV, to adverse effects of the medications they were taking (Bernays and Rhodes, 
2009; Brashers et al., 1999; Furlotte and Schwartz, 2017; Siegel et al., 1999), or sometimes to their 
mental health and cognitive capacity (Furlotte and Schwartz, 2017). The lack of knowledge around 
cause was reported to trigger anxiety because this could signify disease progression.  
Uncertainties related to symptoms also seemed to be linked to the aging process of PLWHIV. 
For instance, older adults living with HIV appeared to question the cause of the symptoms and 
were unsure if these were part of growing older or of HIV progression itself (Furlotte and 
Schwartz, 2017; Rosenfeld et al., 2014; Solomon et al., 2014). As a participant remarked: “You’ve 
never been 50 before you have got HIV. So you never know whether it’s HIV”  (Rosenfeld et al., 
2014, p. 23). 
Disease Progression. There were several reports of participants experiencing difficulties 
with the unpredictable nature of the disease and its progression. Many described the episodic 
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nature of the condition and how it caused a sense of uncertainty for the future (Cochrane, 2003; 
Solomon et al., 2014). One older participant exemplified this stating: “I do have these troughs and 
peaks – and I’m thinking – well, will I get one more peak?”(Rosenfeld et al., 2014, p. 26). Another 
participant questioned the meaning of their AIDS diagnosis because their CD4 count often 
fluctuated above and below the diagnosis criterion (Crossley, 1998). Participants in different 
studies also expressed their concern for the impact that the condition would have on their longevity 
(Davis et al., 2006; Perrett et al., 2013; Rosenfeld et al., 2014) 
There were several reports of the effects of unexpected improvements with the condition which 
appeared to result in increased uncertainty for the future (Brashers et al., 1999; Cochrane, 2003). 
Many older adults who contracted the virus prior to the introduction of HAART, described having 
experienced perplexity at their own survival and the uncertainties related to having to re-engage 
with life and re-entering old social roles again after having accepted the inevitability of their death 
(Furlotte and Schwartz, 2017).  
Health Care Systems and Competing Sources of Knowledge. The selected studies spanned 
across different health care systems. This allowed for some of the similarities and differences in 
the provision of HIV treatment to surface. While uncertainty related to access to treatment was not 
reported in any of the more recent studies published in the UK and USA, a study based on 
interviews in Serbia and Montenegro reported chronic unreliability around the delivery of HAART 
(Bernays and Rhodes, 2009). In this study, participants reported that their uncertainty around 
accessing treatment was influenced by a perceived lack of authority and trust towards health care 
professionals. 
In the USA, where treatment delivery is comparatively more consistent, health care 
provider’s credibility and authority also surfaced as a theme in the reports of PLWHIV (Brashers 
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et al., 2000).  This seems to be particularly important in a context where medications are believed 
to be in constant development and new information, whether of medical or lay origin, is in constant 
supply. PLWHIV reported often being confronted with the uncertainties that arose through 
disparities between official medical narratives of HAART and the narratives based on lived 
experience of its use (Davis et al., 2006). Furthermore, participants in some studies also reported 
their difficulty in sometimes receiving discordant information from different health care 
professionals and experiencing scenarios where doctors disagreed on appropriate courses of 
treatment or where alternative information available might be discordant with medical opinion 
(Brashers et al., 2000; Furlotte and Schwartz, 2017). In Zambia, incongruencies between lay 
knowledge and medical knowledge were posing PLWHIV the dilemma of which source of 
knowledge to trust and which treatment course to follow (Wringe et al., 2009).  
These studies seem to indicate that conflicting discourses and systems of knowledge can be major 
sources of IU for PLWHIV and often form the backdrop through which they have to navigate other 
medical uncertainties such as uncertainty in treatment provision, the long term effects of treatment, 
the choice of treatment regimen,  and the interpretation of medical information (Brashers et al., 
2003; Cochrane, 2003; Davis et al., 2006). 
Personal Sources of Uncertainty Related to HIV. PLWHIV described how the 
unpredictable nature of the condition impacted their ability to make middle and long-term life 
plans (Cochrane, 2003; Davis et al., 2006; Weitz, 1989).  
 In the US some interviewees reported the dilemma of taking risks in career progression. They 
were concerned about the possibility of losing health coverage if they became ill when they started 
their new job (Brashers et al., 1999, 2003). In the UK, participants recounted their dilemmas of 
deciding to remain in employment and managing the unpredictable nature of their condition or to 
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stop working and apply for disability allowance (Crossley, 1998). Participants reflected on the 
impact these decisions had on their professional and personal identities in addition to the potential 
loss of valued roles.  However, they  also discussed the potential gains of ending employment and 
being  able to focus on their health (Crossley, 1998; Perrett et al., 2013). In the US, financial 
consequences of these decisions were also frequently mentioned in relation to the consequences 
of long-term medication costs and the implication of not being able to save money for older age 
(Brashers et al., 1999; Solomon et al., 2014). Family planning was also reported to be a source of 
uncertainty due to difficulties in accessing family planning support and risks associated with 
onward transmission during pregnancy and/or birth (Crossley, 1998; Davis et al., 2006).  
 Finally, older PLWHIV in the UK who identified as sexual and gender minorities 
expressed concerns for their future housing and for the inability of current older adult residential 
services to provide for their specific health needs, especially considering the lack of residential 
housing designated for LGBT communities (Furlotte and Schwartz, 2017).  
HIV-stigma and Uncertainty Related to Disclosure. In the selected studies, HIV related 
stigma was often reported as a substantial hurdle for PLWHIV. Interviewees frequently reported 
experiencing uncertainty around who to disclose their HIV status to and what the outcome of 
disclosure might be (Brashers et al., 2003). Disclosure in effect meant the loss of control of 
sensitive information to third parties   that could result in loss of social support, housing, prestige 
or employment (Wringe et al., 2009). 
In Wringe et al. (2009), PLWHIV described avoiding HIV treatment clinics due to the risk 
of being seen by others from their communities and being identified as being HIV positive. 
Participants to this and other studies described the risks of their medication being found by others, 
and potentially disclosing their HIV status (Campbell et al., 2010). Further perceived risk of 
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unintentional disclosure of HIV-status were also related to fears of potential changes in facial 
appearance that are often associated with specific medications (Davis et al., 2006). This was 
reported to impact treatment choice and medication adherence. 
While most studies reported experiences of stigma related exclusively to HIV,   participants 
in the study by Furlotte and Schwartz (2017) spoke of the multi-layered nature of stigma related 
to their HIV status. A participant, for instance, spoke of their uncertainty at disclosing their mental 
health diagnosis within an HIV peer-support group and having to manage this in order to protect 
themselves from feared negative responses and possible loss of support. 
In summary, PLWHIV reported experiencing uncertainty around disclosure of their HIV 
status due to the potentially negative response of friends, family and community members. 
Participants in these studies reported concerns related to the potential loss of access to support and 
social networks. 
Managing HIV-related Uncertainty 
Seeking Information. Some participants in studies by Yarbrough et al. (2001) and Weitz 
(1989)  explained that they tended to seek information (e.g. temperature monitoring or seeking 
advice from health care professionals) when symptom patterns felt unusual. Being active in 
researching information pertinent to a specific condition was reported as helping interviewees 
understand their condition better to reduce uncertainty (Brashers et al., 2000; Davis et al., 2006; 
Furlotte and Schwartz, 2017; Weitz, 1989). Participants also explained that educating themselves 
about their conditions allowed them to feel like they could respond appropriately to illness events 
(Davis et al., 2006; Weitz, 1989) and helped them to communicate with health care professionals 
and take collaborative decisions about their health care (Davis et al., 2006). 
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In two studies PLWHIV reported investing time and energy in accessing HIV-clinics, groups 
and events because they could increase the probability of learning new useful information about 
their condition (Brashers et al., 2004; Bernays and Rhodes, 2009). Peer-support groups were also 
reported to be particularly helpful as participants were less likely to experience stigma or 
judgmental behaviour from others (Brashers et al., 2004). They also found that peers were 
sometimes more able than professionals to provide accurate or meaningful descriptions of illness 
events, such as medication side effects (Brashers et al., 2004). 
Somewhat less frequently, participants reported seeking information with the aim of 
increasing uncertainty. Participants recounted seeking information on alternative therapies and/or 
experimental medical trials which might increase their chances of improved health and wellbeing. 
While this may help to increase hope for some participants, it also involves uncertainty with 
regards to the effectiveness of these alternative therapies and treatments  (Davis et al., 2006). 
Avoiding Information. There are several accounts by participants of the role of avoidance 
of information in managing IU. Information avoidance reduces exposure to potentially distressing 
knowledge and preserves hope. 
Participants in a study by Brashers et al. (2000) reported avoidance behaviour following a 
period of information seeking. Seeking information was reported as being overwhelming at times, 
due to the quantity and sometimes upsetting content of new information. This could lead to 
engaging in a form of intermittent information avoidance. A similar process was described within 
the context of uncertain treatment delivery. Participants explained “rationing” contact with other 
PLWHIV was a way of controlling information flow and reducing exposure to potentially alarming 
information (Bernays and Rhodes, 2009). 
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Though there are many accounts of the usefulness of peer support groups for PLWHIV, 
participants in some studies explained how these groups were sometimes more stressful than 
helpful due to the distress generated by others sharing their illness related experiences (Brashers 
et al., 2000; Weitz, 1989). Participants reported this information would sometimes lead them to 
form frightening forecasts for their own futures. Avoiding peer support groups was therefore 
important for some participants as a way to avoid the apparent certainty of a future involving pain, 
disability and even death. In avoiding such groups, PLWHIV could sustain their own hope for a 
different future.  
With regard to illness symptoms, some participants reported preferring to maintain a degree 
of ambiguity around their symptoms, especially if learning the cause of the symptoms was 
signifying deterioration. They reported that maintaining ambiguity facilitated the hope that  
symptoms were merely transitory and not significant (Siegel et al., 1999).  
Similarly, in Yarbrough et al. (2001), PLWHIV spoke about not acknowledging or validating 
physical sensations such as chills or night sweats as symptoms of fever. These participants 
explained they would avoid taking their temperature and “ride out” their fever until it broke.  
Accepting Uncertainty and Becoming Hopeful. Some participants recounted gaining new 
perspectives through the process of accepting their HIV-diagnosis and learning to live in the 
present (Katz, 1998). Participants in Cochrane (2003) and Weitz, (1989) explained how accepting 
HIV-related uncertainty in their lives meant they could not make long term plans. They did not 
want to make  far reaching plans because they did not want to experience the frustration or 
disappointment that would come should their health interfere with the achievement of their goals.  
This meant adapting to living their life “one day at a time” (Cochrane, 2003, p. 385; Weitz, 1989, 
p.276). 
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In more recent studies, participants described a tendency to make longer term plans for 
their future as they became accustomed to living with HIV with increased optimism (Perrett et al., 
2013). These participants were able to think about past times of extreme uncertainty and hardship 
and reflect on their being able to get through them. These reflections gave participants hope for 
the future in spite of feeling vulnerable. Similarly, participants in Davis et al., (2006)  observed 
the exceptional and unexpected technological advances that had been made over the decades and 
considered the substantial improvements these advances meant for their illness trajectories. Davis 
et al., (2006) argued that this allowed participants to reframe their IU around hope of continued 
technological development and medical advancements.  
Social Support. Participants reported the importance of discussing new HIV-relevant 
information with friends, family and professionals in helping them manage uncertainty. As one 
participant explained, this process helped “by validating knowledge, plans, and feelings” (Brashers 
et al., 2004; p. 314). At times, supportive others helped deciding when to seek new information or 
when not to. Some participants reported finding it useful at times when friends and family fostered 
avoidance by refusing to talk about HIV-related topics (Brashers et al., 2004). Family and friends 
were also reported acting as advocates. This kind of instrumental support was reported as helpful 
in enhancing the perception of support availability – which in itself helped   individuals to feel less 
threatened by the unknown  (Brashers et al., 2009). 
As already discussed, some participants reported the usefulness of fostering social networks 
with other PLWHIV as a way of increasing exposure to up-to-date information. Social networks 
were also argued by (Brashers et al., 2009) to help PLWHIV develop decision-making and self-
advocacy skills. 
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Peer-support groups were reported by both adults and children as being particularly helpful 
in the normalising of experiences in a context with less risk of judgement (Brashers et al., 2004; 
Campbell et al., 2010).  
In summary, supportive others were reported to assist PLWHIV by regulating information 
seeking and avoidance, providing instrumental support, encouraging the development of new 
coping skills and conveying acceptance and validation. 
Synthesis of Quantitative Research 
In line with evidence from other studies on the impact of IU with other chronic health conditions, 
HIV-related IU appeared to have a strong predictive relationship to self-reports of quality of life 
in a cross-sectional survey of 125 PLWHIV (Frain et al., 2008). In contrast to other research, this 
study also explored the predictive power of medical markers of illness progression (i.e. CD4 
counts) on quality of life. The researchers found that quality of life was not predicted by illness 
progression, as measured by CD4 cell counts. However, it should be considered that CD4 counts 
were relatively high for most of the participants and the majority of them were reportedly 
asymptomatic. It is therefore possible that should the sample have included a larger proportion of 
symptomatic participants with lower CD4 counts, these might have reported significantly lower 
levels of quality of life. This is important to consider because disease progression and the 
experience of ambiguous symptoms could be postulated to moderate the relationship between IU 
and other health outcomes such as quality of life. 
All four quantitative surveys reviewed in this paper reported moderate to strong relationships 
between various forms of social support (i.e. health care professionals, family, friends) and IU, 
where higher levels of reported social support were related to lower levels of IU (Frain et al., 2008; 
Sajjadi et al., 2015; Shannon and Lee, 2008; Santacroce, 2000) . While three of the four studies 
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were carried out in the USA, one study (Sajjadi et al., 2015) was based on an Iranian sample, 
thereby providing some evidence of the cross-cultural validity of these results. A small 
longitudinal survey carried out by Shannon and Lee (2008) also reported a moderate inverse 
relationship between IU and social support. However, this relationship was only significant when 
participants reported intense sources of uncertainty (i.e. when participating mothers living with 
HIV were waiting for their new-born baby’s HIV test results). These results differ from previous 
literature in that they would seem to suggest that the presence and intensity of sources of 
uncertainty, can potentially moderate relationships between IU and social support.  
Finally, a randomised waiting-list control design reported by Brashers et al (2017) tested an 
intervention aimed at improving participant’s skills in managing IU. The intervention aimed at 
improving participant’s communication and increasing access to social support in their 
community. This study provided evidence for a moderate size effect of the intervention on 
participant’s IU. However, it is important to note that the waiting-list control group had fewer 
participants likely due to attrition. It is possible that some participants with higher levels of IU (or 
very symptomatic participants) might have discontinued their participation in the study, thereby 
impacting the intervention’s effect size. Unfortunately, neither effect size nor attrition were 
discussed by Brashers et al (2017). Overall, evidence from Brashers et al (2017) suggests that 
improving the ability of individuals to access helpful social support can reduce IU for PLWHIV 
and improve quality of life. 
In summary, these results bring substantial quantitative evidence of the importance of the social 
environment in the management of IU of PLWHIV. However, in one study, the presence and 
intensity of sources of uncertainty was found to moderate the strength of the relationship of IU to 
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social support. Furthermore, IU was found to be a better predictor of quality of life than markers 
of disease progression. 
Discussion 
The aim of this review was to explore the experiences of IU of PLWHIV and to gain an 
understanding of how these uncertainties are managed. 
Twenty-three studies were selected for review and analysis, of which eighteen were qualitative 
and five quantitative studies. Themes identified in the qualitative studies reflected past research in 
other chronic conditions but also brought to surface some aspects of uncertainty specific to living 
with HIV. Quantitative studies also reflected theory and previous findings in populations with 
other chronic conditions. These findings will now be discussed with the aim of identifying 
limitations to the research and areas of further study. 
 Mishel’s model (Mishel et al., 1991) proposes that cognitive schemata of illness are 
dynamically influenced by the ability of an individual to process information derived by the 
‘stimuli frame’ (e.g. disease pattern, predictability of symptoms ) and by ‘structural providers’ 
(e.g. social support network, health care system, welfare system etc.). The appraisal of IU is then 
postulated to moderate the coping mechanisms individuals engage in. 
Structural Providers 
Several reports provided evidence of aspects of structural providers which were specific to the 
experiences of ‘PLWHIV’. Ample quantitative and qualitative research has identified the 
importance of social support in managing IU. However, in contrast to people diagnosed with many 
other chronic conditions, PLWHIV have to contend with stigma related to the illness and the 
potential impact this has on their ability to access social support (Brashers et al., 2003; Campbell 
et al., 2010; Davis et al., 2006; Solomon et al., 2014; Wringe et al., 2009). Especially for PLWHIV, 
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social contact can be both a resource for managing uncertainty while also being a source of 
uncertainty itself. Within the reports of HIV-stigma, what also surfaced through qualitative 
analysis was that, because many PLWHIV identify with minoritised communities, their 
experiences of accessing social support are also susceptible to other forms of stigma as exemplified 
by participants in Furlotte and Schwartz (2017). This, potentially further restricting their access to 
social resources in the management of uncertainty. 
 The review evidenced further dilemmas specific to the structural providers of older 
PLWHIV. Four of the nineteen qualitative studies specifically consulted samples of older adults 
(Furlotte and Schwartz, 2017; Rosenfeld et al., 2014; Siegel et al., 1999; Solomon et al., 2014). 
The reports in these studies described the experiences of the first cohort to age with the condition. 
In spite of progress in treatment, older PLWHIV expressed their awareness of the limitations of 
current medical knowledge with regards to long-term treatment and aging with the condition. 
Furthermore, participants in this cohort expressed concerns for the ability of current support 
systems to cater for their future needs (Furlotte and Schwartz, 2017; Solomon et al., 2014).  
 Similarly to individuals suffering from other chronic conditions, the uncertainty of whether 
to leave work or stay in work was also reported (Brashers et al., 1999, 2003; Crossley, 1998). This 
structural obstacle is what appears to be the manifestation of an inflexibility of welfare and 
employment systems across national contexts in addressing the needs of individuals with chronic 
conditions, such as PLWHIV. 
 Another important aspect of structural providers reported in one of the studies included in 
this review was that of unreliability of treatment provision (Bernays and Rhodes, 2009). While 
this aspect was only encountered in one study, it reflected the reality of the 12.6 million individuals 
globally who are still not accessing treatment (UNAIDS, 2020).  
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Stimuli Frame  
Participants in the qualitative studies included in this review confirmed that making sense of 
symptoms and disease progression caused great uncertainty around the meaning of illness events 
(Bernays and Rhodes, 2009; Brashers et al., 1999; Furlotte and Schwartz, 2017; Rosenfeld et al., 
2014; Siegel et al., 1999; Yarbrough et al., 2001). These descriptions fall in line with previous 
findings and with Mishel’s model of uncertainty in illness while also highlighting the particular 
ambiguity of HIV clinical presentation and treatment. Of note were older PLWHIV who in 
multiple studies reported their difficulties at discerning illness and treatment related symptoms 
from normal aging – and the uncertainty this caused (Furlotte and Schwartz, 2017; Rosenfeld et 
al., 2014; Siegel et al., 1999; Solomon et al., 2014). Furthermore, review of quantitative studies 
posed the question of whether symptom severity might interact with other factors influencing 
uncertainty, such as social support (Shannon and Lee, 2008). It is feasible that social support gains 
particular valance in reducing IU during a particularly distressing and painful time. In interpreting 
these results however, it should be noted that Shannon and Lee (2008) did not adopt the Mishel 
Uncertainty in Illness Scale adopted in most quantitative literature in the field, thus posing the 
question of whether this result may also be related to the measure used.  
Cognitive Capacity 
Cognitive impairment was at times described as a source of IU in older PLWHIV (Furlotte and 
Schwartz, 2017). However, a lack of research investigating the effects of cognition on the 
experiences of IU of PLWHIV was evident. This is an area of particular importance for PLWHIV, 
especially with regards to the first aging cohort of individuals living with the condition and the 
frequency of HIV-associated cognitive impairment (Alford and Vera, 2018). 
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Appraisal of Illness Uncertainty and Coping 
There were different reports of IU being appraised as threat and the link of this appraisal to 
avoidance and information seeking. Examples of when IU was appraised as opportunity were scant 
and reported only when certainty of a negative outcome was imminent (Davis et al., 2006; Weitz, 
1989). This is a phenomenon present in the wider literature on IU (McCormick, 2002). Lack of 
research renders it difficult to discern differences specific to PLWHIV in the appraisal of 
uncertainty as opportunity.  
Participants also described accepting uncertainty in their lives – though it appears that a cohort 
difference may be emerging: while in several of the studies participants told of the impossibility 
of planning for the future and having to live ‘day by day’(Cochrane, 2003; Weitz, 1989), others in 
a more recent study described a process of adjustment to uncertainty that lead to the realisation 
that there was little to adjust to in the short term while holding the awareness that challenges lay 
ahead in years to come (Perrett et al., 2013). These latter accounts are only found in one study of 
eight men in the UK. However, its striking difference could arguably be attributed to advances in 
treatment and fewer experiences of illness in the lives of newer cohorts of PLWHIV.  
Limitations of the Studies 
Most of the studies reported here were cross sectional and were not able to explore the way 
different factors influence IU over time. For example, this potentially limits our understanding of 
the mechanisms involved in the dynamic process of IU appraisal.   
A further limitation of the research reviewed here was that it showed a large focus on the 
relationship between IU as threat and negative psychological outcomes. This is particularly true 
for quantitative research and it limits our understandings of the appraisal process of IU as 
opportunity in PLWHIV. It is possible that the self-report measure of IU used in four of the five 
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quantitative studies (and indeed in most quantitative research on IU) is not sensitive to experiences 
of uncertainty as opportunity. If this were the case it would be cause of concern for a method effect 
across the majority of the quantitative literature which has used the Mishel Uncertainty in Illness 
Scale (Mishel, 1997). Social desirability and self-selection are also likely to have influenced the 
results in these studies, especially considering the relationship between illness uncertainty and 
avoidance and its potential impact on motivation to participate to research studies on HIV. 
The studies identified in this review showed there to be an under-representation of women, trans 
people and children. This reflects a phenomenon present in other HIV fields of research and is 
likely to result in the omission of important experiences specific to these populations (Loutfy et 
al., 2013).  
Furthermore, in reviewing the quality of the studies, it is noteworthy that many of the qualitative 
studies had little or no reference to bias with the exception of Weitz (1989) and Cochrane (2003). 
An example of lack of reflectiveness in the research process can also result in a lack of 
transparency. An example of this was the fact that three of the studies from Brashers and their 
colleagues (Brashers et al., 2000, 2003, 2004) appeared to be sourced from the same sample though 
no reference of this was made. This is important to consider because it can lead to biased findings 
being repeated in publications.  
Lastly, the majority of research sprung from European and north American contexts. It is important 
to consider the possible bias that similar cultural understandings of uncertainty may contribute to 
the results of this review. Indeed, Babrow et al. (1998)  cite Levine when considering that while 
in some cultures the essence of understanding may be seen as a complete lack of ambiguity, in 
other cultural contexts, indeterminacy may be conceived as the very nature of knowledge (Levine, 
1985). 
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Research Implications 
The following recommendations stem from the considerations discussed previously in this section. 
• Further research into the processes involved in appraising uncertainty as opportunity and 
the specific behavioural and cognitive strategies related to it are warranted; 
• Longitudinal study of IU is warranted to gain better understanding of the dynamic nature 
of the appraisal of IU. Specifically, how appraisal and particular forms of avoidance of 
PLWHIV change over time may be of interest: an example of this would be to explore the 
relationship between IU appraisal and treatment adherence. 
• There was a small number of quantitative research exploring IU in PLWHIV, thus 
warranting further quantitative research in this population. The use and, potentially, the 
development of other measures of IU would further validate the extant quantitative 
literature. 
• There were no quantitative accounts of how experiences of discrimination and HIV-stigma 
may affect IU. It could be postulated that individuals identifying with multiple minoritised 
communities who have been subjected to high levels of discrimination may struggle 
accessing social support and mistrust health care systems, and as a consequence experience 
higher levels IU and that this may be linked to worse outcomes.  
• Several populations of PLWHIV were underrepresented in the literature reviewed here. 
Indeed, different portions of the population, such as women, trans persons, children, 
individuals with minoritised ethnic backgrounds etc. may experience different forms of IU 
and manage it differently. Further research focusing on underrepresented groups is needed. 
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• Literature reviews of empirical research from non-European and north-American countries 
published in other languages than English would allow to further explore the cultural 
differences in discourse around IU as well as identifying gaps in the literature. 
• Finally, the lack of research investigating the impact of cognition on the experiences of IU 
in PLWHIV warrants further exploration of this relationship. 
Conclusions 
In summary, PLWHIV experience a broad range of uncertainties related to living with the 
condition. The major sources of uncertainty identified by a hybrid inductive/deductive thematic 
analysis were: the medical aspects of the condition, the consequences of the illness on the person’s 
professional, financial and relational contexts, and the social intricacies of living with a highly 
stigmatised condition. PLWHIV reported managing these uncertainties through the interplay of 
seeking information and avoidance strategies while also relying on different structures of social 
support. Some participants to the studies also described a process of adaptation to uncertainty 
which in some cases allowed them to stay hopeful for the future. Quantitative literature replicated 
findings in populations of individuals with different chronic conditions and converged with 
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Abstract 
Background and aims: Illness uncertainty is related to worse health outcomes of individuals with 
chronic conditions. Theory and research suggest social support and adverse social experiences may 
play important roles in the experiences of illness uncertainty. Because people living with HIV are 
more likely to carry a burden of multiple stigmatised identities it was the aim of this research to 
explore the relationships between measures of discrimination and social support to illness 
uncertainty and in turn, to explore their predictiveness of quality of life. 
Methods: 125 people living with HIV completed an online questionnaire containing measures of 
quality of life, illness uncertainty, social support, frequency of discrimination, and count of 
attributed stigmatised characteristics.  Demographic data were also collected. Two sets of 
regressions controlling for demographics were carried out: a hierarchical regression was used to 
identify correlates of illness uncertainty; a multiple regression was adopted to model predictors of 
the previous regression and illness uncertainty on quality of life. 
Results: The first regression showed positive moderate relationships of both measures of 
discrimination and an inverse moderate relationship of social support to illness uncertainty. In the 
second regression model, Illness uncertainty showed a negative moderate relationship to quality 
of life and was found to be a stronger predictor than social support.  
Conclusions: People living with HIV subjected to multiple forms of discrimination can experience 
higher levels of illness uncertainty, thus potentially impacting their health outcomes. 
Further research needed and clinical implications are discussed.  
 
Keywords: Illness uncertainty, HIV, Stigma, Discrimination, Social support  
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Introduction 
Living with HIV-related Uncertainty 
Treatment of the human immunodeficiency virus (HIV) has made impressive progress over the 
last decades radically improving life expectancy (Palella et al., 1998) and quality of life (Liu et al., 
2006) of people living with HIV (PLWHIV). The development of highly active antiretroviral 
treatment (HAART) has meant that HIV can now be treated as a chronic condition and that 
PLWHIV can expect the same life-expectancy as their HIV-negative peers, provided they access 
treatment early enough and can adhere to it (May, Gompels, et al., 2014). In spite of these 
improvements, PLWHIV have to contend with complex decisional dilemmas and sources of 
uncertainty related to the management of the condition and the multiple unfolding impacts it can 
have on their lives (Bravo et al., 2010). These sources of uncertainty related to illness can range 
from struggling to make sense of physical symptoms (Yarbrough et al., 2001), to managing 
conflicting information from health care providers and other sources of authority (Brashers et al., 
2000; Furlotte and Schwartz, 2017). Other forms of uncertainty can originate from personal aspects 
of living with the condition, such as potential impacts on career progression (Brashers et al., 2003) 
and financial trajectories (Brashers et al., 1999; Solomon et al., 2014) or also family planning 
(Crossley, 1998). Furthermore, an important source of IU for PLWHIV is having to manage the 
stigma associated with the condition and the uncertainty around negotiating disclosure of one’s 
HIV-positive status (Brashers et al., 2003; Davis et al., 2006).  
Quantitative research across a variety of chronic conditions has consistently shown IU to 
be strongly related to mental and physical outcomes of wellbeing (Wright, Afari, and Zautra, 
2009). Greater levels of IU have shown to be linked to increased levels of depression and anxiety, 
to higher levels of avoidant forms of coping, which in turn are also related to lower levels of quality 
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of life (Guan et al., 2020; Hoth et al., 2013; Mullins et al., 2017; Padilla et al., 1992; Pahlevan 
Sharif et al., 2017; Reich et al., 2006; Schiele et al., 2019). Furthermore, a longitudinal study was 
able to show that IU predicted clinical outcomes of individuals suffering from chronic obstructive 
pulmonary disease (Hoth et al. 2013). This literature describes the important role that IU plays in 
the experiences of people living with chronic conditions and indicates new areas of possible 
clinical intervention.  
Uncertainty in Illness Theory (UIT) was proposed by Mishel (1988, 1990) and has been 
the most prominent theory in explaining uncertainty in chronic and acute illnesses (Wright et al., 
2009). UIT defines uncertainty as “the inability to determine the meaning of illness related events 
that occurs in situations where the decision-maker is unable to assign definite values to objects and 
events and /or is unable to accurately predict outcomes because sufficient cues are lacking” (Mishel 
et al., 1991, 256). The theory suggests that the extent to which an individual will experience 
difficulty in making sense of an illness event will depend on how predictable the illness course is 
and how familiar or ambiguous the symptoms are. The model also suggests that an individual’s 
cognitive capacity and aspects of their support systems (i.e. the availability, quality and complexity 
of services as well as forms of social support) will influence their ability to make sense of the 
illness event. As an example, ambiguous symptoms that change in presentation and intensity over 
time and are incongruent with a person’s expectations, coupled with a complex health care system 
and poor social support, could be expected to decrease the person’s ability to form a stable 
cognitive representation of the illness event. According to UIT this would result in the cognitive 
state we experience as illness uncertainty (IU). The model also describes how an individual’s 
appraisal of IU as either beneficial or a threat is linked to different forms of coping that can impact 
outcomes such as the person’s quality of life and disease progression (Padilla et al., 1992). Based 
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on her model, Mishel developed the Mishel Uncertainty in Illness Scale (MUIS) (Mishel, 1981, 
1997) which has been used widely to study the effects of IU in chronic and acute conditions.  
Social Context and Illness Uncertainty 
Consistent with UIT, positive experiences of social support have been found to be related 
to lower levels of IU (Brashers et al., 2004; Hoth et al., 2015; Sajjadi et al., 2015; Sammarco, 2001; 
Shannon and Lee, 2008). UIT posits that this is due to the role that supportive social networks can 
play in providing individuals with new illness related information and in supporting them process 
it, while also providing structural support (Brashers et al., 2004). Interventions aiming to support 
access to social support have shown efficacy in lowering IU (Brashers et al., 2017). Nevertheless, 
not all social interactions are experienced positively, and some studies exploring the impact of 
adverse social interactions have found these to be related to higher levels of IU (Shannon and Lee, 
2008). In a study by Hoth et al., (2015) for instance, perceived criticism from family was found to 
be positively associated with IU in people suffering from chronic obstructive pulmonary disease. 
In a study investigating the relationship between illness related stigma and IU, Blake et al., (2018) 
were able to show that individuals living with sickle cell anaemia reporting higher levels of illness 
related stigma also reported higher levels of IU. These results suggest that adverse social 
experiences such as stigma and discrimination are related to higher levels of IU and could be 
important in further elucidating the mechanisms leading to negative health outcomes. These 
mechanisms could be of particular importance for individuals living with chronic conditions that 
are subject to varied and intense forms of stigma.   
Intersectional Stigma and HIV-related Uncertainty 
Goffman describes stigma as a process where a person or group is denied full social 
acceptance due to an attribute or behaviour that is discredited by the dominant culture (Goffman, 
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1974). Stigma encompasses prejudices, discriminatory behaviours, practices and policies aimed at 
reproducing systems of inequality and maintaining privileges of the dominant sections of society. 
Research in the social sciences has investigated the ways in which characteristics such as race, 
gender or health impact privilege and disadvantage of both individuals and communities (Turan et 
al., 2019). While much of this research has focused on exploring the impacts of singular forms of 
stigma, individuals often embody several memberships to stigmatised groups.  The concept of 
‘intersectional stigma’ has emerged in order to thematise and explore the effects and consequences 
of living with multiple forms of stigma and is particularly relevant to the experiences of PLWHIV 
(Turan et al., 2019).  
In high-income countries, HIV has been overrepresented in populations particularly 
vulnerable to stigma, such as:  men that have sex with men (Public Health England, 2018; Purcell 
et al., 2012); men and women from minoritised ethnic groups (National AIDS Trust UK, 2014; 
Prejean et al., 2011); people who inject drugs (Prejean et al., 2011; Public Health England, 2018), 
and people that identify as trans (Herbst et al., 2008; Public Health England, 2018). Studies 
exploring the convergence of multiple stigmatised identities have underscored the relative severity 
of HIV-stigma while also confirming the cumulative potential of different forms of stigma. 
Identifying an individual as HIV-positive and in addition as IV-drug user or sex-worker increased 
the level of stigma attributed by students (Crandall, 1991) and by health care workers (Chan et al., 
2008; Mannetti and Pierro, 1991; Rogers et al., 2014). Furthermore, the cumulative experiences of 
racial discrimination with HIV-related stigma was found to be related to reduced disclosure and 
reduced treatment adherence (Bogart et al., 2010; Fletcher et al., 2016) Similar results were found 
in a sample of transgender women, where lower access to HIV-related health care compared to 
cis-gender individuals was attributed to transphobia (Sevelius et al., 2014).  
 
 - 49 - 
In fact, stigma is known to be a primary cause of social exclusion (Popay et al., 2008) and 
to have a deterring effect on help-seeking behaviours (Clement et al., 2015). For example, in a UK 
survey exploring the experiences of PLWHIV individuals that also identified as trans reported 
more frequently being excluded from family gatherings and experiences of being delayed or 
refused healthcare (Hibbert et al., 2018). It could be argued that because of the experience of active 
forms of social exclusion, individuals experiencing higher levels of stigma and discrimination 
would likely have reduced access to social resources. According to UIT, reduced social resources 
would then lead to experiencing higher levels of IU. This would be particularly true for individuals 
vulnerable to multiple forms of stigma who could potentially find accessing social support that 
feels safe, more difficult.  
In their review of intersectional stigma in health, Turan et al. (2019) described different 
quantitative approaches in the exploration of intersectional stigma. A common approach has been 
that of adopting constructs that measure experiences of stigma and discrimination related to 
multiple stigmatised identities. An example of this are measures that  allow respondents to report 
both multiple stigmatised identities attributable to their experiences of discrimination as well as 
the frequency of these incidents (Williams et al., 1997).  
Study Aims and Hypothesis   
PLWHIV have to manage numerous uncertainties related to living with the condition. This can be 
of particular importance due to evidence showing that IU is related to quality of life and potentially 
to illness progression. Furthermore, while social support has been shown to reduce measures of 
IU, evidence suggests that adverse social experiences, such as health stigma, are related to higher 
levels of IU. Because PLWHIV are more likely to carry a burden of multiple stigmatised identities, 
exploring the relationship between multiple forms of stigma and IU is warranted. It is in fact likely, 
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that individuals with a higher stigma burden will experience higher levels of social exclusion, thus 
presenting higher vulnerability to IU. Because the social environment is so instrumental in the 
meaning making process leading to the cognitive state of IU, it was the aim of this study to explore 
the relationships between social support, stigma and IU. A further aim of the study was to replicate 
previous findings regarding the relationship between IU and quality of life in a sample of 
PLWHIV. Based on these objectives the following hypothesis were formulated. 
 
Because numerous studies reported the protective effect of social support on IU it is expected that: 
H.1 higher levels of reported social support are associated to lower levels of reported illness 
uncertainty. 
 
Individuals that experience multiple forms of stigma are at higher risk of social exclusion and thus 
likely have reduced access to social resources. According to UIT, reduced social resources would 
lead to experiencing higher levels of IU. Thus, it is hypothesised that: 
H.2 A higher number of reported stigmatised characteristics are associated to higher levels of 
illness uncertainty. 
 
Similarly, it would be expected that reports of frequent experiences of discrimination would also 
be related to higher levels of social exclusion, which would result to higher levels of illness 
uncertainty. Thus, it is hypothesised that: 
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Lastly, based on the extant literature linking lower levels of IU to better quality of life it is 
hypothesised that: 
H. 4 Lower levels of illness uncertainty are associated to higher levels of reported quality of life. 
Methods 
Design 
A cross-sectional study design was adopted based on convenience sampled survey data. Each 
participant carried out one battery of measures. 
Procedure 
The study protocol was approved by the Salomons Institute’s Ethics Panel (appendix F). The Code 
of Human Research Ethics of the British Psychological Society was adhered to (British 
Psychological Society, 2014).  
Hyperlinks to the internet survey were distributed and advertised online through third sector 
agencies, social media (Appendix M) and HIV related forums. Survey questionnaires were stored 
online and delivered through Qualtrix. On accessing the online survey participants were provided 
with a participant information sheet (appendix G). Participants were assured of the privacy and 
anonymity protecting the information they submitted and were informed of the opportunity to 
decline participation up to the point of survey completion. On deciding to participate, participants 
accessed a consent sheet (appendix H) which they agreed to by pressing on a ‘continue’ button. 
No incentives were provided for completing the questionnaire. The measures were presented in a 
randomised sequence. To be included in the analysis participants had to complete and submit the 
questionnaire. 
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Participants 
A total of 125 participants completed and submitted their questionnaires. Individuals were 
excluded from the study if they: were under 18 years of age; had not been diagnosed with HIV for 
at least over a year; had not shared their diagnosis with at least a friend or family member; were 
not proficient in reading English; did not live in either Australia, Canada, Ireland, New Zealand, 
the United Kingdom or the United States. 
Measures 
All measures adopted in the study can be viewed in appendix I 
Demographic Data 
Participants were asked to share the following demographic data: age, gender, ethnicity2, number 
of years of completed education, employment status, relationship status3, number of years since 
being diagnosed with HIV. 
Illness Uncertainty 
Uncertainty was measured with the community version of the Mishel Uncertainty in Illness Scale 
(MUIS-C) (Mishel, 1981, 1997). The measure consists of 23 items that are rated on a 5-point Likert 
type scale ranging from 1 = ‘strongly disagree’ to 5 = ‘strongly agree’. The items explore areas in 
which individuals experience various forms of uncertainty (e.g. if they can tell when the illness is 
getting better or worse, if symptoms change unpredictably, the level of treatment and health care 
system complexity, the effectiveness of treatment, the clarity of communication with health care 
professionals etc.)  
 
2 The national statistics ethnicity coding frameworks of each respective country were adopted. To aid statistical 
analysis these categories were collapsed into White, Black, Asian and other ethnic background. 
3 To aid statistical analysis categories were collapsed into ‘single’ and ‘in a relationship’. 
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The scale is a modified version of the Adult version of the MUIS (MUIS-A) and has been adapted 
for use with persons living with chronic conditions by deleting 10 items which referred to 
hospitalization and medical intervention. Items are summed to form the total score which can range 
from 23 to a maximum of 115. As the total score increases so does the level of illness related 
uncertainty. The internal consistency of the MUIS-C ranged from .74 to .92 in 18 studies based on 
individuals with a range of chronic conditions (Mishel, 1997).  
The MUIS-C shares all of its items with the MUIS-A which was reviewed by a panel of experts 
during its development stages. Evidence for the construct validity of the MUIS-A was also reported 
following a factor analysis of data based on a sample of 616 participants yielding four constructs: 
ambiguity of symptoms, complexity, inconsistency of information and unpredictability (Mishel, 
1997). Similarly, Reinoso and Türegün (2016) also identified a two-factor structure to the MUIS-
C and high internal consistency at .91 thereby providing further evidence for the validity and 
reliability of the measure. No studies exploring convergent or divergent validity were reported. 
The construct has shown to preserve psychometric properties in Spanish, Norwegian and Chinese 
populations (Hagen et al., 2015; Torres-Ortega and Peña-Amaro, 2015) 
Perceived Social Support  
Social support was measured with the Multidimensional Scale of Perceived Social Support (Zimet 
et al., 1990). This measure consists of twelve items that are rated on a 7-point likert-type scale 
ranging from 1 = ‘strongly disagree’ to 7 = ‘very strongly agree’. Items are summed and divided 
by their number to form the total score which can range from 1 to 7. As the total score increases 
so does the level of perceived social support. Some evidence for the construct validity of the 
measure was provided through a factor analysis. Three factors were identified in different studies 
and consistently reflected the three sub-groups of social support the measure was designed to query 
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i.e. family, friends and significant others. The internal consistency of the scale was reported to 
range from .85 to .95 (Canty-Mitchell and Zimet, 2000). Several studies have replicated 
psychometric properties in different cultural contexts (Mantuliz and Castillo, 2002; Wang et al., 
2017; Wongpakaran et al., 2018) 
Quality of Life 
 The Medical Outcome Study HIV (MOS-HIV) (Wu et al., 1997) consists of 35-item measure that 
are rated with 3,5 and 6-point Likert-type response responses. Subscale items are transformed to 
form scores that range from 0 to 100 with higher scores representing better quality of life and 
health. A final total score is computed by adding subscales and dividing them by their number. 
The MOS-HIV assesses several dimensions of quality of life: general health perceptions, physical 
function, role function, social function, pain, mental health, fatigue, health distress and transition4. 
Several studies reported internal consistency to range between .75 and .94 across different 
subpopulations of PLWHIV (Henderson et al., 2010; Wu et al., 1997). Multi-trait analysis also 
brought forward evidence for convergent and divergent validity of the measure across different 
stages of the illness (Wu et al., 1997). 
Experiences of Discrimination  
The Everyday Discrimination Scale (EDS) (Williams et al., 1997) consists of two sets of items: 
‘discrimination frequency’ and ‘discrimination attributions’. Discrimination frequency consists of 
nine items that are rated on a likert-type scale ranging from 1 = ‘never’ to 6 = ‘almost every day’. 
The measure queries generic experiences of discrimination a respondent may have encountered 
over the period of 12 months (e.g. “You are called names or harassed”). The item scores are then 
 
4 The health transition item assess whether the participant has had a self-perceived change in health status over the 
last four weeks. 
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summed to create a frequency score of experiences of discrimination that ranges from 6 to 54. 
Higher scores indicate a higher frequency of experiences of discrimination.  
For ‘discrimination attributions’, participants are asked: “What do you think are the main 
reasons for these experiences [of discrimination]? Participants can then choose from a list of 10 
characteristics the main reasons they attribute to having been discriminated against. Participants 
can also choose the option ‘other’ to include characteristics that were not included in the list. The 
count of attributed characteristics is then computed. 
The EDS has consistently demonstrated good internal consistency (Reeve et al., 2011; Shariff-
Marco et al., 2011) and construct validity (Krieger et al., 2005), retaining psychometric properties 
and validity across different cultural groups (Chan et al., 2012; Gonzales et al., 2016)  
Data Analysis 
Data were analysed with SPSS version 21. Categorical sample characteristics were summarised 
and compared to national statistics to gauge sample representativeness. Averages and distributions 
of the measures adopted in the study were computed together with reliability coefficients. Because 
recruitment took place at the start of the COVID-19 pandemic, the relationship between IU and 
sampling time was also explored by computing a scatterplot and a linear regression of IU on 
sampling time. Relationships between variables employed in the study were initially explored with 
bivariate correlations. In order to control for confounding effects, demographic variables 
exhibiting significant moderate correlations with outcome variables were included as covariates in 
inferential analysis.  
Hypothesis were tested with two linear regressions: a) a hierarchical linear model, and b) 
a linear multiple regression. Assumptions for linear regression modelling were tested. 
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a) Hierarchical regressions can be employed to build on previous research. This type of 
regression allows the introduction of variables at different stages of analysis and 
compares the change in explanatory power of a regression model. Covariates and 
predictors adopted in previous research are initially added to the model followed by 
new predictors.  Following this procedure, IU was regressed in a stepwise manner on 
social support followed by experiences of discrimination (frequency of discrimination, 
and count of characteristics attributed) in order to confirm previous research linking 
social support to IU (i.e hypothesis 1) and to explore the predictiveness of 
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b) A second multiple regression regressed quality of life on IU in order to confirm 
hypothesis four. This regression included covariates and all measures adopted in the 
study so to allow for comparison of predictiveness of the different variables. 
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Statistical Power and Sample Size  
Sample size was estimated in order to ensure the analysis would have 95% probability of detecting 
a medium size effect (f2=.15) if present. The program G*Power was employed for this computation 
(Erdfelder et al., 2009). Alpha was set at .05 and a necessary sample size of 119 participants was 
returned for a linear regression model with eight predictors. In order to prevent familywise error 
inflation with the use of regression, Mundfrom et al. (2006) recommend adopting a multiple 
comparisons test. Midway et al. (2020) suggest the use of Bonferroni corrections for planned 
comparisons based on parametric data. A Bonferroni correction based on the number of hypotheses 
being tested and the number of comparisons being carried out was calculated: 
  Bonferroni corrected Alpha = Alpha / (Total number of hypotheses tested) 
= .05/7 = .007 
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The Bonferroni corrected Alpha was adopted to test for significance of inferential statistics. 
Results 
Demographics 
Table 1 summarises the demographic characteristics of participants that completed the survey. 
Table 1 
Participant demographics (N=125) 
 M Median SD Skewness Kurtosis Range 
Age (Years) 46.7 49.0 11.5 -.85 -.91 18-71 
Education (Years) 15.9 16.0 5.5 -.30 .15 2-29 
Year since tested HIV+ 13.9 11 9.9 .78 -.49 1-35 
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In a relationship 
Divorced/Separated 
Widowed 












Gay or Lesbian 
Bisexual 
Other 








































One hundred and twenty-five participants had been diagnosed HIV-positive for a mean average of 
13.9 years, they were predominantly male (n = 106), middle aged (median = 49 years) of white 
ethnic background (n=98) and non-heterosexual (n = 108). The majority of participants had some 
form of employment (72.6 %) and while half was single, divorced or separated (48.0%) the other 
half was involved in some form of long-term relationship (48.8%). The large majority of 
participants lived in the UK (n = 74) and the United States (n = 36). 
 In comparing UK National demographics to the demographics of the UK sub-sample of 
this study (see Table 2), it becomes apparent that the UK sub-sample is not nationally 
representative as it under-represents women and black and ethnic minorities. Age distribution in 
the sample appears to be more reflective of national statistics though older age individuals (i.e.65 
and over) are not represented in this sub-sample. 
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Table 2 
Comparison of UK sample characteristics with UK national statistics of people living with HIV 
 
























































A missing data analysis was carried out and eight values were found to be missing across five 
variables. The small rate of missing values poses little threat of bias to the analysis and a multiple 
imputation was regarded unnecessary. In order to include all cases in the analysis and to minimise 
effects of listwise deletion missing values were replaced with corresponding means (Acock, 2012).  
As shown in Table 3, internal consistencies computed returned comparable values to the ones 
reported in previous research and provided further evidence of the reliability of all measures.  
 
5 National AIDS Trust UK (2020). 
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While means and distributions of the scores are dependent on the sample, descriptive statistics of 
the measures employed in this study were found to be within the same ranges as to those of 
previous research. Means and standard deviations computed for the MUIS-C were comparable to 
the descriptive statistics of several studies cited in Mishel (1997). Similarly, subscale means and 
standard deviations of the MOS-HIV were found to be comparable to those reported in Wu et al. 
(1997) and, as would be expected, showed higher means when compared to studies based on 
symptomatic clinical samples Wu et al. (1992)6. Means for the EDS are bound to differ depending 
on the subpopulation explored by a given study. However, studies showed similar distribution 
properties  (Clark et al., 2004). Means and standard deviations of the MSPSS were comparable 
those reported in  Zimet et al. (1990). 
Table 4 shows bivariate correlations between the variables explored in the study. As would be 
expected from theory and previous research, statistically significant and strong negative 
relationship were found between a) the MUIS-C and MOS-HIV and b) between the MSPSS and 
the MUIS-C. All directions of statistically significant correlations reported in Table 4 were in line 
with theory and previous research. Both the MOS-HIV and the MUIS-C presented similar 
correlation coefficients in strength to four variables: years since tested positive, relationship status, 
employment status and education history. Variable means for UK and USA sub-samples were 
computed in the form of a bar chart and returned overlapping confidence intervals (see appendix 
J). The bar chart suggests there are no major differences between the groups that could confound 
statistical analysis.  
Data harvesting started on the 7th of February 2020 and took place over a period of 77 days. 
The World Health Organization declared a global pandemic on the 11th of March 2020 (World 
 
6 As cited in Wu et al (1997) 
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Health Organization, 2020a). It is plausible that a pandemic breakout might impact the way 
participants score on IU. Figure 1 shows a scatterplot of scores of the MUIS-C across sampling 
time in days. The scatterplot seems to suggest a drop in scores across sampling time. A linear 
model regressing the MUIS-C on the sampling time was computed. Sampling time came close to 
being predictive of IU (MUIS-C), β=-.155, t (124)=-1.74 at p=.084 and the model explained 2.4% 
of variance in MUIS-C scores. While not statistically significant at p<.05, this model indicates 
sampling time could potentially act as confounding variable in the analysis. 
 
Figure 1 
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Table 3 
Descriptive statistics of measures (N=125) 













































-.67 (.22) -.51 (.43) .95 
MSPSS 5.0 5.2 1.53 1-7 -.73 (.22) -.18 (.43) .94 
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Table 4 
Bivariate correlations of variables (N=125) 
  1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
1 Gender             
2 Ethnicity .05            
3 Age -.273** -.143           
4 Years since tested positive -.059 .096 .459**          
5 Sampling time .114 -.099 -.03 -.057         
6 Relationship Status -.022 -.109 .024 -.039 .217*        
7 Employment -.017 .06 -.375** -.282** .148 .203*       
8 Education history -.058 -.005 .173 .109 .078 .187* .167      
9 QoL (MOS-HIV) -.058 .042 .019 -.257** .132 .251** .414** -.255**     
10 
 
Discrimination (EDS):  
Frequency .111 .125 -.195* .094 -.132 -.270** -.182* .229* -.573**    
11 Attributions .343** .247** -.168 .134 .031 -.230* -.064 .125 -.375** .509**   
12 Perceived Social Supp (MSPSS) .123 .034 -.095 -.176* .138 .452** -.218* -.245** .551** -.441** -.202*  
13 Illness Uncertainty (MUIS-C) .094 -.021 .084 .225* -.155 -.254** .338** .247** -.727** .603** .406** -.530** 
 ** Correlation is significant at the 0.01 level (2-tailed).          
 * Correlation is significant at the 0.05 level (2-tailed).          
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Hypothesis Testing 
Hierarchical Multiple Regression on Illness Uncertainty  
The hierarchical linear regression model presented in this analysis is based on several assumptions. 
For linear regressions to compute unbiased parameters it is necessary that residuals are normally 
distributed. The probability plot of standardised regression residuals against the standardised 
predicted values in appendix L suggests a mostly even distribution around 0. Furthermore, Lumley 
et al. (2002) was able to show that, linear regression models based on least square methods are 
robust to breaches of normality. The probability plots also indicate that neither heteroscedasticity 
nor non-linearity were of particular concern in this sample (Field, 2009). Furthermore, a Durbin-
Watson test of 1.843 was computed to test for independence of errors. As the value is close to 2 
the assumption of independence of errors was held (Savin and White, 1977). Multicollinearity 
statistics indicated a small degree of multicollinearity. Table 4 did not show strong correlation 
coefficients between predictors. Variance inflation factors computed in the analysis ranged 
between 1.068 and 1.645 which is below the critical value of 10 (Daoud, 2018). Furthermore, all 
tolerance levels computed in the analysis were > .2 (Daoud, 2018) indicating the absence of 
problematic multicollinearity.  
Table 5 summarizes the results for the hierarchical linear regression model for IU. The 
change in R² was significant across all steps of the hierarchical regression, indicating that after 
adjusting for covariates (i.e. relationship and employment status, educational history, and time 
since receiving an HIV diagnosis), adding the predictors social support, discrimination attributions 
and discrimination frequency produced a statistically significant improvement in predicting IU. 
Specifically, the model at step four was statistically significant (F(7, 124)=18.77, p<0.0001) and 
explained 48.2% of the variance in IU.  
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H. 1 High levels of social support are associated to lower levels of illness uncertainty. 
In line with previous research, social support was moderately associated with IU. The model shows 
that PLWHIV reported higher levels of social support if they reported lower levels of IU (b=-
3.366, SE=.894, p=.0001), hypothesis one was therefore supported. 
H. 2 Experiencing multiple forms of discrimination is associated to higher levels of 
illness uncertainty. 
 Discriminations attributions was moderately associated to IU at step three of the 
hierarchical regression. PLWHIV that attributed a higher number of stigmatised characteristics to 
their experiences of discrimination reported higher levels of IU (b=3.245, SE =.773, p= .0001), 
hypothesis three was therefore supported. 
However, introducing discrimination frequency to the model at step four, reduced the 
relative importance of discrimination attributions in explaining variance of IU (as can be observed 
from the drop in β-coefficient from step three to step four) and rendered it statistically non-
significant (b=1.569, SE =.818, p= .058). In light of these results and the moderate bivariate 
correlation between discrimination frequency and discrimination attributions (r(123)=.51, 
p=.0001) it is suggested that discrimination frequency may partially mediate the effect between 
discrimination attributions and uncertainty in illness.  
H. 3 Frequency of discrimination experiences are associated to higher levels of illness 
uncertainty. 
Reporting higher frequency experiences of discrimination (i.e. discrimination frequency) 
was moderately associated to higher scores of self-reported IU (b=.567, SE =.131, p= .0001. In 
fact, discrimination frequency was the strongest predictor in the model (β=.359) overall, even more 
so than social support (β = -.302).  
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SPSS v.21 output also provides coefficient estimates of excluded variables at various stages 
of the hierarchical regression. In the absence of discrimination attributions, at step two, the 
standardised coefficient of discrimination frequency rises to β=.434. This means that assuming all 
other predictors are kept constant, one standard deviation increase in discrimination frequency will 
result in a .43 standard deviation increase in IU. 
Overall, these results support hypothesis three and suggest that discrimination frequency 
accounts for more variance in IU than any other predictor in the model.
 




Results of hierarchical linear regression model predicting illness uncertainty7 (N = 125) 
 
 
7 The following effect size heuristics were employed in the interpretation of the results: “β < 0.20 is considered a weak effect, β between 0.2 and 0.5 is considered 
a moderate effect, and β >0.5 is considered a strong effect” (Acock, 2014, p.727) 
 
Step 1 Step 2 Step 3 Step 4
b (SE) β sig. b (SE) β sig. b (SE) β sig. b (SE) β sig.
Years since tested positive .314 .15 .181 .038 .186 .138 .107 .179 .116 .13 .067 .375 .138 .121 .079 .259
Relationship status
Single Reference Reference Reference Reference
In a relationship -5.536 2.917 -.16 .06 .645 2.897 .019 .824 2.107 2.736 .061 .443 2.068 2.55 .06 .419
Employment
Not employed Reference Reference Reference
Employed -8.235 3.424 -.212 .018 -7.185 3.109 -.185 .023 -7.751 2.916 -.2 .009 -6.653 2.73 -.171 .016
Years of education -.634 .266 -.202 .019 -.382 .246 -.122 .123 -.291 .231 -.093 .212 -.202 .217 -.064 .352
Social support -5.008 .96 -.45 .0001 -4.663 .903 -.419 .0001 -3.366 .894 -.302 .0001
Discrimination
Attribution 3.245 .773 .303 .0001 1.569 .818 .146 .058
Frequency .567 .131 .359 .0001
Change statistics
R2 Change .2 .149 .085 .078
Sig. of change in R2 .0001 .0001 .0001 .0001
Adjusted R2 .173 .321 .404 .482
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One hundred twenty-one participants (i.e. 96.8 % of the participants to this study) reported 
experiences of discrimination. A median of two stigmatised characteristics were attributed to these 
experiences. Table 6 shows the count of characteristics attributed to experiences of discrimination 
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by ethnicity. As can be seen from the table the top-ranking characteristics attributed were ‘race’ 
for Black and Asian ethnic groups and ‘sexuality’ for White and ‘other’ minoritised ethnic groups. 
Nationality was also the second and third top-ranking attributed characteristic for black and ‘other’ 
ethnicities respectively. ‘HIV-Status’ was the second top ranking attributed characteristic for 
White and Black ethnicities and third top ranking for ‘other’ ethnic minorities. PLWHIV that also 
selected ‘other characteristic’ reported being discriminated against also because of their: mental 
health, disability and self-confidence.  These results provide insight into some of the experiences 
of discrimination of PLWHIV constituting this sample but are unlikely to represent other sections 
of the population under-represented here (e.g. women, trans men and women, gender diverse 
individuals etc.). What is evident from this sample, however, is that experiences of discrimination 
of PLWHIV are varied and reflect a multitude of systematic societal oppressors. 
Multiple Regression on Quality of Life  
Table 7  
Results of linear regression model predicting quality of life (N = 125) 
  b (SE) β sig. 
Years since tested positive -.106 .117 -.056 .368 
Relationship status     
Single Reference    
In a relationship 1.881 2.451 .05 .444 
Employment     
Not employed Reference    
Employed 7.672 2.681 .181 .005 
Years of education .129 .208 .038 .538 
Social support 2.504 .907 .206 .007 
Illness Uncertainty -.464 .089 -.426 .0001 
Discrimination     
Attributions -.782 .796 -.067 .328 
Frequency -.272 .135 -.158 .046 
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Adjusted R2 .599    
Sig. .0001    
 
Table 7 summarises the results of a second linear regression that was computed on quality of life 
to test hypothesis four. Assumptions of linearity, normality and homoscedasticity were 
investigated through the inspection of residual against predicted value probability plots (appendix 
M). The assumptions were confirmed. Multicollinearity was assessed by inspecting variance 
inflation factors (1.151 to 1.909) and tolerance levels (.489 to .869) which were all within the 
acceptable range. A Durbin-Watson test confirmed the condition of independence of residual error 
(d = 2.037).  The model explains 59.9% of the variance in quality of life of PLWHIV and was 
found to be highly significant (F(8, 124)=24.187, p<0.0001). PLWHIV that reported working in the 
last 12 months (b=7.672, SE =2.681, p= .005) and having access to social support (b=2.504, SE 
=.907, p= .007) reported higher levels of quality of life.  
H. 4 Lower levels of illness uncertainty are associated to higher levels of reported 
quality of life. 
A moderate strength association was found between IU and quality of life. PLWHIV that reported 
experiencing lower levels of IU (b=-.464, SE =.089, p= .0001) reported higher levels of quality of 
life. Hypothesis four was thus supported. Neither discrimination attributions (b=-.782, SE =.796, 
p= .328) nor discrimination frequency (b=-.272, SE =.135, p= .046) were significant predictors of 
quality of life in this regression model. 
Standardized coefficients enable the comparison of the relative strength of the variable in 
predicting quality of life. As can be seen from Table 7 IU accounts for most of the variance in 
quality of life in this model. In fact, one standard deviation increase in IU is shown to be associated 
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with a .43 standard deviation decrease in quality of life, assuming all other variables are kept 
constant. 
 Figure 1 presents a visual summary of the results of both regressions.  
 
Figure 2 



























Hierarchical regression on illness uncertainty: Model 4, Adjusted R Squared = .482 
Regression on quality of life, Adjusted R squared = .599 
 
+ = statistically non-significant i.e. p > .007 
* = statistically significant at p = .007 
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Discussion 
The main aim of this study was to explore how the social environment of PLWHIV may be related 
to their experiences of IU. Specifically, to explore the relationship between stigma, social support 
and IU. Further, this study also aimed to replicate in a population of PLWHIV, findings showing 
an inverse relationship between IU and quality of life.  
Main Findings 
This study found that higher levels of reported social support were related to lower levels of 
reported IU. These findings are in line with previous research exploring this relationship in 
different populations of individuals living with chronic conditions (Hoth et al., 2015; Lien et al., 
2009; Sammarco, 2001) and PLWHIV (Sajjadi et al., 2015). They are also in line with UIT and 
provide further support for the notion that supportive family members, friends and partners play 
an important role in the experiences of IU of individuals living with chronic conditions, such as 
HIV. Conversely, reports of higher levels of stigma were found to be related to higher levels of 
reported IU. Specifically, PLWHIV attributing discrimination to multiple stigmatised identities 
tended to report higher levels of IU. Furthermore, reporting a higher frequency of instances of 
discrimination was also associated to reports of higher IU. However, frequency of discrimination 
experiences was found to be a better predictor of IU compared to counts of discrimination 
attributions, as it explained much larger portions of variance in IU. Though no hypothesis was put 
forward in this study as to which sub-measure of stigma would present a stronger relationship to 
IU, this finding poses the question of why this difference was so stark. While the results suggested 
that frequency of discrimination may partially mediate the relationship between discrimination 
attributions and IU, there may be alternative explanations as to why frequency of discrimination 
was a better linear predictor of IU. 
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In their study, Seng et al. (2012) argued that relying on the sum of discrimination 
attributions can be simplistic and may not capture the valences and potential combination effects 
present in the attribution of discrimination to more than one stigmatised identity. In essence, they 
suggest that the experiences of discrimination attributed to one form of stigma may not be 
equivalent when attributed to another form and may thus impact individuals differently. For 
instance, it could be postulated that, PLWHIV experiencing homophobia and HIV-stigma, may be 
more able to access supportive communities, than individuals that experience HIV-stigma and 
racism. While this example is based on conjecture, it would be a plausible hypothesis considering 
the historical involvement of gay communities in HIV anti-stigma campaigning (Clews, 2017). 
The same level of support may not be available for individuals also experiencing racism. 
Identifying such combination effects could be relevant in addressing particular target groups more 
vulnerable to the effects of stigma on IU. At any rate, these results suggest that stigma and 
discrimination may play an important role in the experiences of IU of PLWHIV and that, as shown 
in Table 6, the episodes of discrimination PLWHIV experience are varied and not originating 
exclusively from HIV-stigma. Of particular note is the comparative predictive strength of 
discrimination frequency compared to social support, a predictor whose relevance to IU has been 
established through multiple studies. In fact, based on these results and UIT it could be postulated 
that experiences of discrimination could moderate access to social support, and through this 
process influence the formation of cognitive states that result in IU. The findings in this study, 
however, do not give us insight into such moderation hypotheses. Indeed, others have suggested 
the relationship between health stigma and IU could be explained through different mechanisms, 
such as increased arousal and hypervigilance related to discriminatory experiences which could in 
 
 - 75 - 
turn affect the cognitive processes that lead to IU (Gamwell et al., 2020). These hypotheses require 
further testing. 
Finally, this study was able to replicate previous findings reporting moderate strength 
relationships between IU and quality of life in samples of individuals living with chronic 
conditions (Fortier et al., 2013; Guan et al., 2020; Hoth et al., 2013; Parker et al., 2013; 
Wonghongkul et al., 2006b). Self-reported IU showed a moderate strength relationship to quality 
of life in PLWHIV and explained twice as much variance in quality of life as self-reports of social 
support. These findings provide further support for the relevance of IU in the quality of life of 
PLWHIV. Of note, when viewing the summary of results of both regression analyses (see Figure 
1), are the small non-significant relationships of the two sub-measures of stigma to quality of life 
in spite of numerous studies reporting moderate relationships (Bergeron et al., 2020; Chapman 
Lambert et al., 2020; Logie et al., 2018). The non-significance of these weak relationships could 
in fact be due to a shared covariance of measures of discrimination with IU, as illustrated by the 
bivariate correlation matrix in Table 4. These results could suggest that IU partially mediates the 
relationship between stigma and quality of life. However, a full mediation analysis was not 
completed in this study and Wu and Zumbo (2008) remind us that mediation analysis is a causal 
analysis that should not, ideally, rest on cross-sectional designs as this one. 
Strengths and Limitations 
This study provides a nuanced exploration of the relationship between social environment and IU 
in PLWHIV. To our knowledge, this is the first study that has explored the relationship between 
multiple forms of stigma and IU. However, the fact that the stigma measure employed here was 
not specifically developed for PLWHIV, could mean that many experiences of health-related 
stigma were left uncaptured.  This could have resulted in the under-representation of participant’s 
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experiences of health-related stigma and arguably, may have encouraged those who felt unable to 
report their experiences, to discontinue participating to the survey.  
The study made use of convenience sampling which has resulted in a sample of PLWHIV 
that appears not to be representative of the wider population. In fact, the UK sub-sample of this 
study, is under-representing women, people from Black and Asian ethnic backgrounds and Trans 
people. The effects of self-selection are also likely to have been particularly strong in this sample 
due to the well documented relationship between IU and avoidant coping (Guan et al., 2020). 
Furthermore, it is possible, that experiences of discrimination might systematically impact 
individual’s motivation to participate to the study, thus potentially impacting the sample’s 
composition. It should also be noted that collecting data through the internet excludes individuals 
that may not have online access which in the UK, for example, account for 10% of the population 
(Office for National Statistics, 2019). Self-report measures are known to be vulnerable to social-
desirability and acquiescence (Barker et al., 2002) and in combination with a non-representative 
sample this could have resulted in the alteration of significance and magnitude of some 
relationships. The study did not control for such extraneous variables as illness progression or the 
presence of other conditions. These sources of bias require that caution be used in the interpretation 
and generalization of the results. Caution should also be used in inferring causality of the 
relationships due to the cross-sectional nature of the design employed here.  
Finally, sample size and consequently statistical power posed limitations to the extent of 
inferential statistics that could be employed in this study. For example, the inclusion of interaction 
terms in the multiple regressions would have required much larger sample sizes (Shieh, 2009).  
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Future Research 
Based on the limitations inherent to this study and its main findings, several directions of future 
research have emerged. These results warrant further exploration of the relationships between 
measures of stigma, social support and IU. Specifically, determining if there is a significant 
interaction between measures of stigma and social support on measures of IU would be an initial 
step in exploring the hypothesis that the relationship between social support and IU is moderated 
by stigma and experiences of discrimination. 
 Furthermore, this study raises the question of whether discrimination frequency mediates 
a potential effect of discrimination attributions on IU and whether different combinations of 
discrimination attributions may be differentially related to IU. An idiographic approach to the 
study of these relationships would be more appropriate as it would allow their exploration within 
groups of individuals that share similar characteristics and experiences (Bergman et al., 2003).  
 Finally, the results of this study also warrant further exploration of the relationship between 
experiences of stigma and quality of life and the potential mediating role of IU in this relationship. 
Clinical Implications 
Findings of the current study indicate that PLWHIV might be more vulnerable to IU due to the 
burden of multiple stigmas that this population is confronted with. Though conclusions can only 
be tentative, these results and previous research allow for the following hypothesis. Individuals 
that experience high levels of stigma, potentially experience higher levels of social exclusion and, 
as a consequence, find it more difficult to form coherent cognitive representations of their illness 
related events; This in turn could lead to higher levels of IU; As has been shown by much research 
in the field, IU can often be appraised as threat and lead to affective responses that result in 
avoidant coping styles, such as treatment non-adherence. This hypothesis describes a vicious cycle 
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that can result in continually worsening health outcomes for the individuals experiencing high 
levels of stigma. However, it also offers different sites of intervention. First of all – it identifies 
potential target populations more vulnerable to IU. According to UIT health care professionals are 
central in helping individuals form coherent cognitive representations of illness related events. 
Clinicians have thus the opportunity to identify individuals that are more vulnerable to stigma and 
support them in making sense of their illness events. They can do this in many of the ways that 
have already been discussed elsewhere in nursing literature (Clayton et al., 2018), such as 
supporting them in the reappraisal of uncertainty from stressful to hopeful, or more simply, 
providing information that meet the communication needs of specific patient groups. 
  An alternative site of intervention would be to provide forms of peer-support based on a 
multifaceted understanding of the person’s identity. Buddy programs oriented by the individual’s 
prior experiences of stigma, could for instance facilitate access to social support that might 
otherwise feel threatening. Indeed, interventions based on buddy programs for PLWHIV have 
already been trialled by Brashers et al. (2017). A future adaptation of such program could see 
potential participants express their preference in terms of shared experience they would need to 
have with their buddy, including those that might be related to identifying with one or more 
stigmatised identities. 
 Other sites of intervention are related to staff training at HIV clinical services and could 
consist in sensitising staff to sources of uncertainty that are specific to stigmatised groups of 
individuals and how to support such individuals in managing these uncertainties. Such training 
would naturally be specific to the area and community in which the service was active and would 
need to be rich in service-user knowledge and involvement. 
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Conclusions 
This study expands and builds on previous research evidencing the role of the social environment 
in the experiences of IU of people living with chronic conditions. Specifically, the results showed 
that in a non-representative sample of PLWHIV, frequency of experiences of discrimination and 
counts of attributed stigmatised characteristics were related to higher levels of IU. Furthermore, 
social support was also found to be moderately and inversely related to IU. This study provides 
further support for UIT and its applications. The results suggest that addressing experiences of 
stigma and discrimination in minoritised people living with HIV could impact the level of IU they 
experience, and potentially improve their quality of life. The results also provide further support 
for the use of individual’s social context as site of intervention for the management of IU. 
However, further research exploring the mechanisms involved  in these relationship is warranted 
in order to ascertain causality and gain further understanding of the role that social support may 











 - 80 - 
References 
Acock, A C. (2012). What to do About Missing Values. In P. Harris Cooper (Ed.), APA Handbook 
of Research Methods in Psychology. (pp. 27–50). American Psychological Association. 
https://doi.org/10.1037/13621-002 
Acock, Alan C. (2014). A Gentle Introduction to Stata (4th ed.). Stata Press.  
Arechabala Mantuliz, M. C., and Miranda Castillo, C. (2002). Validacion de una escala de apoyo 
social percibido en un grupo de adultos mayores adscritos a un programa de hipertension de 
la region metropolitana. Ciencia y Enfermeria, 8(1), 49–55. 
Barker, C., Pistrang, N., Elliott, R., and Barker, C. (2002). Research methods in clinical 
psychology : an introduction for students and practitioners. J. Wiley. 
Bergeron, G., Lundy De La Cruz, N., Gould, L. H., Liu, S. Y., and Levanon Seligson, A. (2020). 
Association between racial discrimination and health-related quality of life and the impact of 
social relationships. Quality of Life Research, 29(10), 2793–2805. 
https://doi.org/10.1007/s11136-020-02525-2 
Bergman, L. R., Magnusson, D., and El-Khouri, B. M. (2003). Studying individual development 
in an interindividual context: A person-oriented approach. In Paths through life. Lawrence 
Erlbaum Associates Publishers.  
Blake, A., Asnani, V., Leger, R. R., Harris, J., Odesina, V., Hemmings, D. L., Morris, D. A., 
Knight-Madden, J., Wagner, L., and Asnani, M. R. (2018). Stigma and illness uncertainty: 
adding to the burden of sickle cell disease. Hematology, 23(2), 122-130. 
https://doi.org/10.1080/10245332.2017.1359898 
Bogart, L. M., Wagner, G. J., Galvan, F. H., and Klein, D. J. (2010). Longitudinal relationships 
between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, 
 
 - 81 - 
and sexual orientation among African-American men with HIV. Annals of Behavioral 
Medicine, 40(2), 184-190. https://doi.org/10.1007/s12160-010-9200-x 
Brashers, D. E., Basinger, E. D., Rintamaki, L. S., Caughlin, J. P., and Para, M. (2017). Taking 
Control: The Efficacy and Durability of a Peer-Led Uncertainty Management Intervention 
for People Recently Diagnosed With HIV. Health Communication, 32(1), 11–21. 
https://doi.org/10.1080/10410236.2015.1089469 
Brashers, D. E., Neidig, J. L., Cardillo, L. W., Dobbs, L. K., Russell, J. A., Haas, S. M. (1999). “In 
an important way, I did die”: uncertainty and revival in persons living with HIV or AIDS. 
AIDS Care, 11(2), 201–219. https://doi.org/http://dx.doi.org/10.1080/09540129948090 
Brashers, D. E., Neidig, J. L., and Goldsmith, D. J. (2004). Social support and the management of 
uncertainty for people living with HIV or AIDS. Health Communication, 16(3), 305–331.  
Brashers, D. E., Neidig, J. L., Haas, S. M., Dobbs, L. K., Cardillo, L. W., and Russell, J. A. (2000). 
Communication in the management of uncertainty: The case of persons living with HIV or 
AIDS. Communication Monographs, 67(1), 63–84. 
https://doi.org/http://dx.doi.org/10.1080/03637750009376495 
Brashers, D. E., Neidig, J. L., Russell, J. A., Cardillo, L. W., Haas, S. M., Dobbs, L. K., Garland, 
M., McCartney, B., and Nemeth, S. (2003). The medical, personal, and social causes of 
uncertainty in HIV illness. Issues in Mental Health Nursing, 24(5), 497–522. 
https://doi.org/10.1080/01612840305292 
Bravo, P., Edwards, A., Rollnick, S., and Elwyn, G. (2010). Tough decisions faced by people 
living with HIV: a literature review of psychosocial problems. AIDS Reviews, 12(2), 76–88.  
British Psychological Society. (2014). Code of Human Research Ethics. 
https://www.bps.org.uk/sites/bps.org.uk/files/Policy/Policy - Files/BPS Code of Human 
 
 - 82 - 
Research Ethics.pdf 
Canty-Mitchell, J., and Zimet, G. D. (2000). Psychometric properties of the multidimensional scale 
of perceived social support in urban adolescents. American Journal of Community 
Psychology, 28(3), 391–400. https://doi.org/10.1023/A:1005109522457 
Chan, K. T. K., Tran, T. V., and Nguyen, T. N. (2012). Cross-Cultural Equivalence of a Measure 
of Perceived Discrimination Between Chinese-Americans and Vietnamese-Americans. 
Journal of Ethnic and Cultural Diversity in Social Work, 21(1), 20–36. 
https://doi.org/10.1080/15313204.2011.647348 
Chan, K. Y., Stoové, M. A., and Reidpath, D. D. (2008). Stigma, social reciprocity and exclusion 
of HIV/AIDS patients with illicit drug histories: A study of Thai nurses’ attitudes. Harm 
Reduction Journal, 5(1), 28. https://doi.org/10.1186/1477-7517-5-28 
Chapman Lambert, C., Westfall, A., Modi, R., Amico, R. K., Golin, C., Keruly, J., Quinlivan, E. 
B., Crane, H. M., Zinski, A., Turan, B., Turan, J. M., and Mugavero, M. J. (2020). HIV-
related stigma, depression, and social support are associated with health-related quality of life 
among patients newly entering HIV care. AIDS Care, 32(6), 681–688. 
https://doi.org/10.1080/09540121.2019.1622635 
Clark, R., Coleman, A. P., and Novak, J. D. (2004). Brief report: Initial psychometric properties 
of the everyday discrimination scale in black adolescents. Journal of Adolescence, 27(3), 363-
368. https://doi.org/10.1016/j.adolescence.2003.09.004 
Clayton, M. F., Dean, M., and Mishel, M. (2018). Theories of uncertainty in illness. In Middle 
Range Theory for Nursing, Fourth Edition. https://doi.org/10.1891/9780826159922.0004 
Clement, S., Schauman, O., Graham, T., Maggioni, F., Evans-Lacko, S., Bezborodovs, N., 
Morgan, C., Rüsch, N., Brown, J. S. L., and Thornicroft, G. (2015). What is the impact of 
 
 - 83 - 
mental health-related stigma on help-seeking? A systematic review of quantitative and 
qualitative studies. In Psychological Medicine, 45(1), 11-27. 
https://doi.org/10.1017/S0033291714000129 
Clews, C. (2017). The AIDS Coalition to Unleash Power (ACT UP). In Gay in the 80s : from 
fighting for our rights to fighting for our lives (pp. 255–259). Troubador Publishing.  
Crandall, C. S. (1991). Multiple stigma and AIDS: Illness stigma and attitudes toward 
homosexuals and IV drug users in AIDS‐related stigmatization. Journal of Community and 
Applied Social Psychology, 1(2), 165-172.  https://doi.org/10.1002/casp.2450010210 
Crossley, M. (1998). “Sick role” or “empowerment”? The ambiguities of life with an HIV positive 
diagnosis. Sociology of Health and Illness, 20(4), 507–531.  
Daoud, J. I. (2018). Multicollinearity and Regression Analysis. Journal of Physics: Conference 
Series, 949(1), 12009. https://doi.org/10.1088/1742-6596/949/1/012009 
Davis, Mark, Frankis, J., Paul;, F., Flowers, P., Paul;, F., and Flowers, P. (2006). Uncertainty and 
“technological horizon” in qualitative interviews about HIV treatment. Health: An 
Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 10(3), 323–
344. https://doi.org/http://dx.doi.org/10.1177/1363459306064489 
Davis, Mary, Ventura, J. L., Wieners, M., Covington, S. N., Vanderhoof, V. H., Ryan, M. E., 
Koziol, D. E., Popat, V. B., and Nelson, L. M. (2010). The psychosocial transition associated 
with spontaneous 46,XX primary ovarian insufficiency: Illness uncertainty, stigma, goal 
flexibility, and purpose in life as factors in emotional health. Fertility and Sterility. 93(7), 
2321-2329. https://doi.org/10.1016/j.fertnstert.2008.12.122 
Erdfelder, E., FAul, F., Buchner, A., and Lang, A. G. (2009). Statistical power analyses using 
G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods, 
 
 - 84 - 
41(4), 1149–1160. https://doi.org/10.3758/BRM.41.4.1149 
Field, A. (2009). Discovering statistics using SPSS. Sage Publications Limited. 
Fletcher, F., Ingram, L. A., Kerr, J., Buchberg, M., Bogdan-Lovis, L., and Philpott-Jones, S. 
(2016). She Told Them, Oh That Bitch Got AIDS: Experiences of Multilevel HIV/AIDS-
Related Stigma among African American Women Living with HIV/AIDS in the South. AIDS 
Patient Care and STDs, 30(7), 349-356. https://doi.org/10.1089/apc.2016.0026 
Fortier, M. A., Batista, M. L., Wahi, A., Kain, A., Strom, S., and Sender, L. S. (2013). Illness 
uncertainty and quality of life in children with cancer. Journal of Pediatric 
Hematology/Oncology, 35(5), 366-370. https://doi.org/10.1097/MPH.0b013e318290cfdb 
Furlotte, C., and Schwartz, K. (2017). Mental Health Experiences of Older Adults Living with 
HIV: Uncertainty, Stigma, and Approaches to Resilience. Canadian Journal on Aging, 36(2), 
125–140. https://doi.org/10.1017/S0714980817000022 
Gamwell, K. L., Roberts, C. M., Espeleta, H. C., Baudino, M. N., Hommel, K. A., Grunow, J. E., 
Jacobs, N. J., Gillaspy, S. R., Mullins, L. L., and Chaney, J. M. (2020). Perceived stigma, 
illness uncertainty, and depressive symptoms in youth with inflammatory bowel disease: The 
moderating effect of mindfulness, 25(9), 1037-1048. Psychology, Health and Medicine. 
https://doi.org/10.1080/13548506.2020.1714062 
Goffman, E. (1974). Stigma: Notes on the management of spoiled identity. Touchstone. 
https://doi.org/10.2307/2575995 
Gonzales, K. L., Noonan, C., Goins, R. T., Henderson, W. G., Beals, J., Manson, S. M., Acton, K. 
J., and Roubideaux, Y. (2016). Assessing the Everyday Discrimination Scale among 
American Indians and Alaska Natives. Psychological Assessment, 28(1), 51–58. 
https://doi.org/10.1037/a0039337 
 
 - 85 - 
Guan, T., Santacroce, S. J., Chen, D. G., and Song, L. (2020). Illness uncertainty, coping, and 
quality of life among patients with prostate cancer. Psycho-Oncology, 29(6), 1019-1025. 
https://doi.org/10.1002/pon.5372 
Hagen, K. B., Aas, T., Lode, K., Gjerde, J., Lien, E., Kvaløy, J. T., Lash, T. L., Søiland, H., and 
Lind, R. (2015). Illness uncertainty in breast cancer patients: Validation of the 5-item short 
form of the Mishel Uncertainty in Illness Scale. European Journal of Oncology Nursing, 
19(2), 113–119. https://doi.org/10.1016/j.ejon.2014.10.009 
Henderson, W. A., Schlenk, E. A., Kim, K. H., Hadigan, C. M., Martino, A. C., Sereika, S. M., 
and Erlen, J. A. (2010). Validation of the MOS-HIV as a measure of health-related quality of 
life in persons living with HIV and liver disease. AIDS Care - Psychological and Socio-
Medical Aspects of AIDS/HIV, 22(4), 483–490. https://doi.org/10.1080/09540120903207292 
Herbst, J. H., Jacobs, E. D., Finlayson, T. J., McKleroy, V. S., Neumann, M. S., and Crepaz, N. 
(2008). Estimating HIV prevalence and risk behaviors of transgender persons in the United 
States: A systematic review. In AIDS and Behavior, 12(1), 1-17. 
https://doi.org/10.1007/s10461-007-9299-3 
Hibbert, M., Wolton, A., Crenna-Jennings, W., Benton, L., Kirwan, P., Lut, I., Okala, S., Ross, 
M., Furegato, M., Nambiar, K., Douglas, N., Roche, J., Jeffries, J., Reeves, I., Nelson, M., 
Weerawardhana, C., Jamal, Z., Hudson, A., and Delpech, V. (2018). Experiences of stigma 
and discrimination in social and healthcare settings among trans people living with HIV in 
the UK. AIDS Care, 30(7), 836-843. https://doi.org/10.1080/09540121.2018.1436687 
Hoth, K. F., Wamboldt, F. S., Ford, D. W., Sandhaus, R. A., Strange, C., Bekelman, D. B., and 
Holm, K. E. (2015). The Social Environment and Illness Uncertainty in Chronic Obstructive 
Pulmonary Disease. International Journal of Behavioral Medicine, 22(2), 223–232. 
 
 - 86 - 
https://doi.org/10.1007/s12529-014-9423-5 
Hoth, K. F., Wamboldt, F. S., Strand, M., Ford, D. W., Sandhaus, R. A., Strange, C., Bekelman, 
D. B., and Holm, K. E. (2013). Prospective impact of illness uncertainty on outcomes in 
chronic lung disease. Health Psychology, 32(11), 1170–1174. 
https://doi.org/10.1037/a0032721 
Krieger, N., Smith, K., Naishadham, D., Hartman, C., and Barbeau, E. M. (2005). Experiences of 
discrimination: Validity and reliability of a self-report measure for population health research 
on racism and health. Social Science and Medicine, 61(7), 1576–1596. 
https://doi.org/10.1016/j.socscimed.2005.03.006 
Lien, C. Y., Lin, H. R., Kuo, I. T., and Chen, M. L. (2009). Perceived uncertainty, social support 
and psychological adjustment in older patients with cancer being treated with surgery. 
Journal of Clinical Nursing, 18(16), 2311-2319. https://doi.org/10.1111/j.1365-
2702.2008.02549.x 
Liu, C., Ostrow, D., Detels, R., Hu, Z., Johnson, L., Kingsley, L., and Jacobson, L. P. (2006). 
Impacts of HIV infection and HAART use on quality of life. Quality of Life Research, 15(6), 
941-949. https://doi.org/10.1007/s11136-005-5913-x 
Logie, C. H., Wang, Y., Lacombe-Duncan, A., Wagner, A. C., Kaida, A., Conway, T., Webster, 
K., de Pokomandy, A., and Loutfy, M. R. (2018). HIV-related stigma, racial discrimination, 
and gender discrimination: Pathways to physical and mental health-related quality of life 
among a national cohort of women living with HIV. Preventive Medicine, 107, 36–44. 
https://doi.org/10.1016/j.ypmed.2017.12.018 
Lumley, T., Diehr, P., Emerson, S., and Chen, L. (2002). The importance of the normality 
assumption in large public health data sets. Annual Review of Public Health, 23, 151–169. 
 
 - 87 - 
https://doi.org/10.1146/annurev.publhealth.23.100901.140546 
Mannetti, L., and Pierro, A. (1991). Health care workers’ reactions to AIDS victims: Perception 
of risk and attribution of responsibility. Journal of Community and Applied Social 
Psychology. 1(2), 133-142. https://doi.org/10.1002/casp.2450010207 
May, M. T., Gompels, M., Delpech, V., Porter, K., Orkin, C., Kegg, S., Hay, P., Johnson, M., 
Palfreeman, A., Gilson, R., Chadwick, D., Martin, F., Hill, T., Walsh, J., Post, F., Fisher, M., 
Ainsworth, J., Jose, S., Leen, C., Glabay, A. (2014). Impact on life expectancy of HIV-1 
positive individuals of CD4R cell count and viral load response to antiretroviral therapy.  
AIDS, 28(8), 1193-1202. https://doi.org/10.1097/QAD.0000000000000243 
Midway, S., Robertson, M., Flinn, S., and Kaller, M. (2020). Comparing multiple comparisons: 
practical guidance for choosing the best multiple comparisons test. PeerJ, 8, 1-26 
https://doi.org/10.7717/peerj.10387 
Mishel, M. H. (1981). The measurement of uncertainty in illness. Nursing Research, 30(5), 259-
263. 
Mishel, M. H. (1988). Uncertainty in Illness. Image: The Journal of Nursing Scholarship, 20(4), 
225–232. https://doi.org/10.1111/j.1547-5069.1988.tb00082.x 
Mishel, M. H. (1990). Reconceptualisation of the uncertainty in illness theory. Journal of Nursing 
Scholarship, 22(4), 256–262. https://doi.org/10.1111/j.1547-5069.1990.tb00225.x 
Mishel, M. H. (1997). Uncertainty in Illness Scales Manual. [Unpublished manuscript]. 
Department of Nursing. University of North Carolina. 
Mishel, M. H., Padilla, G., Grant, M., and Sorenson, D. S. (1991). Uncertainty in Illness Theory. 
Nursing Research, 40(4), 236-240. https://doi.org/10.1111/j.1547-5069.1988.tb00082.x 
Mullins, A. J., Gamwell, K. L., Sharkey, C. M., Bakula, D. M., Tackett, A. P., Suorsa, K. I., 
 
 - 88 - 
Chaney, J. M., and Mullins, L. L. (2017). Illness uncertainty and illness intrusiveness as 
predictors of depressive and anxious symptomology in college students with chronic 
illnesses. Journal of American College Health, 65(5), 352-360. 
https://doi.org/10.1080/07448481.2017.1312415 
Mundfrom, D. J., Perrett, J. J., Schaffer, J., Piccone, A., and Roozeboom, M. (2006). Bonferroni 
Adjustments in Tests for Regression Coefficients. Multiple Linear Regression Viewpoints, 
32(1), 1-6. 
National AIDS Trust UK. (2014). HIV and Black African Communities in the UK. 
https://www.nat.org.uk/sites/default/files/publications/NAT-African-Communities-Report-
June-2014-FINAL.pdf 
National AIDS Trust UK. (2020). HIV in the UK statistics - 2018. https://www.nat.org.uk/about-
hiv/hiv-statistics 





Padilla, G. V., Mishel, M. H., and Grant, M. M. (1992). Uncertainty, appraisal and quality of life. 
Quality of Life Research, 1(3), 155–165. https://doi.org/10.1007/BF00635615 
Pahlevan Sharif, S., Ahadzadeh, A. S., and Perdamen, H. K. (2017). Uncertainty and quality of 
life of Malaysian women with breast cancer: Mediating role of coping styles and mood states. 
Applied Nursing Research, 38, 88-94. https://doi.org/10.1016/j.apnr.2017.09.012 
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., 
 
 - 89 - 
Aschman, D. J., and Holmberg, S. D. (1998). Declining Morbidity and Mortality among 
Patients with Advanced Human Immunodeficiency Virus Infection. New England Journal of 
Medicine, 338(13), 853–860. https://doi.org/10.1056/NEJM199803263381301 
Parker, P. A., Alba, F., Fellman, B., Urbauer, D. L., Li, Y., Karam, J. A., Tannir, N., Jonasch, E., 
Wood, C. G., and Matin, S. F. (2013). Illness uncertainty and quality of life of patients with 
small renal tumors undergoing watchful waiting: a 2-year prospective study. European 
Urology, 63(6), 1122–1127. 
Popay, J., Escorel, S., Hernandez, M., Johnston, H., Mathieson, J., and Rispel, L. (2008). 
Understanding and tackling social exclusion: final report to the WHO Commission on Social 
Determinants of Health from the Social Exclusion Knowledge Network. In WHO 
Commission on the Social Determinants of Health. 
Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Lin, L. S., An, Q., Mermin, 
J., Lansky, A., and Hall, H. I. (2011). Estimated HIV incidence in the United States, 2006-
2009. PLoS ONE, 6(8), 1-13 https://doi.org/10.1371/journal.pone.0017502 
Public Health England. (2018). Progress towards ending the HIV epidemic in the United Kingdom. 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_dat
a/file/821273/Progress_towards_ending_the_HIV_epidemic_in_the_UK.pdf 
Purcell, D. W., Johnson, C. H., Lansky, A., Prejean, J., Stein, R., Denning, P., Gau1, Z., Weinstock, 
H., Su, J., and Crepaz, N. (2012). Estimating the Population Size of Men Who Have Sex with 
Men in the United States to Obtain HIV and Syphilis Rates. The Open AIDS Journal, 6(1), 
98-107. https://doi.org/10.2174/1874613601206010098 
Reeve, B. B., Willis, G., Shariff-Marco, S. N., Breen, N., Williams, D. R., Gee, G. C., Alegría, M., 
Takeuchi, D. T., Stapleton, M., and Levin, K. Y. (2011). Comparing cognitive interviewing 
 
 - 90 - 
and psychometric methods to evaluate a racial/ethnic discrimination scale. Field Methods, 
23(4), 397–419. https://doi.org/10.1177/1525822X11416564 
Reich, J. W., Johnson, L. M., Zautra, A. J., and Davis, M. C. (2006). Uncertainty of illness 
relationships with mental health and coping processes in fibromyalgia patients. Journal of 
Behavioral Medicine, 29(4), 307–316. https://doi.org/10.1007/s10865-006-9054-7 
Reinoso, H., and Türegün, M. (2016). Examining the factor structure of MUIS-C scale among 
baby boomers with hepatitis C. Applied Nursing Research, 32, 111–116. 
https://doi.org/10.1016/j.apnr.2016.06.007 
Rogers, S. J., Tureski, K., Cushnie, A., Brown, A., Bailey, A., and Palmer, Q. (2014). Layered 
stigma among health-care and social service providers toward key affected populations in 
Jamaica and the Bahamas. AIDS Care, 26(5), 538-546. 
https://doi.org/10.1080/09540121.2013.844762 
Sajjadi, M., Rassouli, M., Bahri, N., and Mohammadipoor, F. (2015). The Correlation Between 
Perceived Social Support and Illness Uncertainty in People with Human Immunodeficiency 
Virus/Acquired Immune Deficiency Syndrome in Iran. Indian Journal of Palliative Care, 
21(2), 231–235. https://doi.org/10.4103/0973-1075.156508 
Sammarco, A. (2001). Perceived social support, uncertainty, and quality of life of younger breast 
cancer survivors. Cancer Nursing, 24(3), 212–219. 
Savin, N. E., and White, K. J. (1977). The Durbin-Watson Test for Serial Correlation with Extreme 
Sample Sizes or Many Regressors. Econometrica, 45(8), 1989. 
https://doi.org/10.2307/1914122 
Schiele, S. E., Emery, C. F., and Jackson, J. L. (2019). The role of illness uncertainty in the 
relationship between disease knowledge and patient-reported outcomes among adolescents 
 
 - 91 - 
and adults with congenital heart disease. Heart and Lung, 48(4), 325-330. 
https://doi.org/10.1016/j.hrtlng.2018.10.026 
Seng, J. S., Lopez, W. D., Sperlich, M., Hamama, L., and Reed Meldrum, C. D. (2012). 
Marginalized identities, discrimination burden, and mental health: Empirical exploration of 
an interpersonal-level approach to modeling intersectionality. Social Science and Medicine, 
75(12), 2437–2445. https://doi.org/10.1016/j.socscimed.2012.09.023 
Sevelius, J. M., Patouhas, E., Keatley, J. G., and Johnson, M. O. (2014). Barriers and facilitators 
to engagement and retention in care among transgender women living with human 
immunodeficiency virus. Annals of Behavioral Medicine, 47(1), 5-16. 
https://doi.org/10.1007/s12160-013-9565-8 
Shariff-Marco, S., Breen, N., Landrine, H., Reeve, B. B., Krieger, N., Gee, G. C., Williams, D. R., 
Mays, V. M., Ponce, N. A., Alegrí, M., Liu, B., Willis, G., and Johnson, T. P. (2011). 
Measuring everyday racial/ethnic discrimination in health surveys: How Best to Ask the 
Questions, in One or Two Stages, Across Multiple Racial/Ethnic Groups? Du Bois Review, 
8(1), 159–177. https://doi.org/10.1017/S1742058X11000129 
Shieh, G. (2009). Detecting Interaction Effects in Moderated Multiple Regression With 
Continuous Variables Power and Sample Size Considerations. Organizational Research 
Methods, 12(3), 510–528. https://doi.org/10.1177/1094428108320370 
Solomon, P., O’Brien, K., Wilkins, S., and Gervais, N. (2014). Aging with HIV and disability: 
The role of uncertainty. AIDS Care, 26(2), 240–245. 
https://doi.org/10.1080/09540121.2013.811209 
Torres-Ortega, C., and Peña-Amaro, P. (2015). Adaptación cultural de la escala de incertidumbre 
de Mishel en el paciente tratado con hemodiálisis. Enfermeria Clinica, 25(1), 9–18. 
 
 - 92 - 
https://doi.org/10.1016/j.enfcli.2014.09.002 
Turan, J. M., Elafros, M. A., Logie, C. H., Banik, S., Turan, B., Crockett, K. B., Pescosolido, B., 
and Murray, S. M. (2019). Challenges and opportunities in examining and addressing 
intersectional stigma and health. BMC Medicine, 17(1), 7-22. https://doi.org/10.1186/s12916-
018-1246-9 
Wang, Y., Wan, Q., Huang, Z., Huang, L., and Kong, F. (2017). Psychometric properties of multi-
dimensional scale of perceived social support in Chinese parents of children with cerebral 
palsy. Frontiers in Psychology, 8, 1-6. https://doi.org/10.3389/fpsyg.2017.02020 
Williams, D. R., Yu, Y., Jackson, J. S., and Anderson, N. B. (1997). Racial differences in physical 
and mental health: Socio-economic status, stress and discrimination. Journal of Health 
Psychology, 2(3), 335–351. 
Wonghongkul, T., Dechaprom, N., Phumivichuvate, L., and Losawatkul, S. (2006). Uncertainty 
appraisal coping and quality of life in breast cancer survivors. Cancer Nursing, 29(3), 250–
257. https://doi.org/10.1097/00002820-200605000-00014 
Wongpakaran, T., Wongpakaran, N., Sirirak, T., Arunpongpaisal, S., and Zimet, G. (2018). 
Confirmatory factor analysis of the revised version of the Thai multidimensional scale of 
perceived social support among the elderly with depression. Aging and Mental Health, 22(9), 
1149-1154.https://doi.org/10.1080/13607863.2017.1339778 
World Health Organization. (2020). Coronavirus disease (COVID-19) pandemic. 
https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19 
Wright, L. J., Afari, N., and Zautra, A. (2009). The illness uncertainty concept: A review. Current 
Pain and Headache Reports, 13(2), 133–138. https://doi.org/10.1007/s11916-009-0023-z 
Wu, A. D., and Zumbo, B. D. (2008). Understanding and Using Mediators and Moderators. Social 
 
 - 93 - 
Indicators Research, 87(3), 367–392. https://doi.org/10.1007/s11205-007-9143-1 
Wu, A. W., Lichter, L., and Richardson, W. (1992). Quality of life in patients receiving 
clarithromycin for mycobacterium avium complex infection and AIDS. VIII Internetional 
Conference on AIDS/III STD World Congress. 
Wu, A. W., Revicki, D. A., Jacobson, D., and Malitz, F. E. (1997). Evidence for reliability, validity 
and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of 
Life Research, 6(6), 481–493. https://doi.org/10.1023/A:1018451930750 
Yarbrough, S., Cole, L., and Holtzclaw, B. (2001). “Riding it out”: living with uncertainty of HIV-
related fever at home. Southern Online Journal of Nursing Research, 2(2), 1–23. 
Zimet, G. D., Powell, S. S., Farley, G. K., Werkman, S., and Berkoff, K. A. (1990). Psychometric 
Characteristics of the Multidimensional Scale of Perceived Social Support. Journal of 













 - 94 - 
Appendices  
Appendix A. Terms adopted in systematic search 
 
HIV or Human Immunodeficiency Virus or AIDS or Acquired Immune Deficiency 
Syndrome  
AND uncert* or insecur* or unpredictab* or Ambigu* or certain* or doubt* or incertit* or 
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Weitz (1989) 0 2 2 2 2 2 2 1 2 2 85 
Katz (1996) 2 2 2 2 2 1 2 2 2 1 90 
Crossley (1998) 
 
2 2 2 2 2 2 1 1 2 0 80 
Brashers et al. 
(1999) 
1 2 2 2 2 1 2 2 2 0 80 
Siegel et al. (1999) 0 2 2 2 
 
 
2 2 1 2 2 0 75 
Brashers et al. 
(2000) 
 
2  2 2 2 2 2 2 2 2 0 90 




2 2 2 2 2 1 1 1 2 0 75 
Brashers et al. 
(2003) 
 
2  2 2 2 2 2 2 2 2 0 90 
Cochrane (2003) 
 
2 2 2 2 1 2 2 2 2 1 90 
 Brashers et al. 
(2004) 
 
2  2 2 2 2 2 2 2 2 0 90 
Davis et al. (2006) 
 
2 2 2 2 2 2 1 1 2 0 80 
Wringe et al. (2009) 
 
2 2 2 1 2 2 2 2 2 1 90 
Bernays and 
Rhodes (2009) 
2 1 2 2 2 2 2 1 2 0 80 
Campbell et al. 
(2010) 
 
2 2 2 2 2 2 2 1 2 1 90 
Perrett et al. (2013) 2 2 2 2 2 2 2 1 2 0 85 
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Rosenfeld et al. 
(2014) 
 
2 2 2 2 2 2 2 1 2 0 85 
Solomon et al. 
(2014) 
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Appendix D. Summary of sudies included in the review ordered by year of publication 
Study Country Sample Design Illness 
uncertainty 
measure 
Relevant findings Quality assessment 
Weitz (1989) US N= 23 Men, 2 Women 
Age= 30-39 




Sampling location: HIV 
Project contact list, 
mainstream press 
Time since diagnosis: / 
Disease progression: 







Interviews lasted 2 to 5 






invited for a second 
interview 4-6 months 
after the first. 2 
declined, 2 moved 
address and 8 died. 
n/a The author identified 
uncertainties around: why 
the person had contracted 
HIV, how the illness would 
affect their lives, which 
professionals to trust and 
what information. The 
study also elucidates how 
individuals cope by 
generating “normative 
frameworks” to 
comprehend their situation 
in illness, and how this is 
related to coping tactics 
such as “taking a day at a 
time”. 
Strengths: This is the first study to 
report experiences of uncertainty in 
PLWHIV. Bias was discussed 
explicitly. Sample includes people 
that lived in non-highly urbanised 
areas. The sample was reported to be 
in some respect representative of 
demographics of PLWHIV in that 
state. The author provides examples 
to support findings. 
 
Weaknesses: No clear statement of 
study aim made. Only one coder 
adopted during the analysis thus 
increasing potential for bias. 
Katz (1996) CA N= 9 Men, 1 Women 
Age= 27-50 




Sampling location: HIV 
clinic, Urban area 










with each participant 
were recorded and 
transcribed. 
 
Participants, health care 
providers were asked to 
review and give 
feedback of results. The 
material was also 
 Adjustment to uncertainty 
involves gaining a new life 
perspective through 
experiencing survival of 
the diagnosis, developing 
ways of self-care, living in 
the present, seeking 
support networks and 
appreciating positive 
changes that HIV diagnosis 
has brought. 
Strengths: Results were discussed 
with clinical staff and interviewees 
for feedback. The analysis was also 
audited by external researcher thus 
increasing the credibility of the 
results. 
 
Weaknesses: Very little data about 
sample demographics making it 
difficult to gage whose perspectives 
were being voiced.  
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UK N= 31 Men, 4 Women 
Age x̄ = 38.5 




Sampling location: Peer 
group 







90min interviews were 
carried out between 
1994 and 1996. 
 
Interviews were semi-
structured and designed 
to address physical, 
psychosocial and 
existential dimensions 
of LWHIV. Verbatim 
transcripts were coded. 
 Participants explained their 
experiences of uncertainty 
related to a general 
skepticism towards 
medical knowledge and a 
tendency of health care 
professionals to refuse lay 
knowledge. 
Strengths: The article is rich in 
transcript extracts to support the 
extraction of themes. This is the only 
study reported that included 
participants living with hemophilia. 
 
 
Weaknesses: little description 
regarding participant demographics 
recruitment and selection. Bias is 
not addressed or explicitly 
discussed. Coding process is not 
described in detail. 
Brashers et al. 
(2000) 
 
US N= 18 men, 3 women 
Age x̄ = 38 
Sexual orientation: >gay 





HIV clinic, Urban 
Time since diagnosis: 
5.5 years 
Disease progression: 









Data collected through 
focus groups 1.5-2 
hours in length. One 
researcher facilitated 
while other noted order 
of speaking to aid 
transcription. Data was 
independently coded 
and then compared to 
then agree on set of 
categories and continue 
with coding. Iterative 
n/a Revival emerged as a major 
source of uncertainty. 
Uncertainty related to hope 
around the future 
effectiveness of 
medication; the uncertainty 
about “re-entering” life into 
old social roles as a person 
with a chronic illness; the 
uncertainty around re-
entering old relationships; 
the financial cost of 
lifelong medication 
dependence; uncertainty 
around the level of quality 
of life. 
Strengths 
The study selected a subpopulation 
of individuals at a more advanced 
stage of the disease, at a historically 
relevant moment i.e. following 
introduction of HAART. This 
insured homogeneity of illness 
progression in the sample. 
The authors provided several 
examples of raw data linked to 
themes. 
Researches initially coded data 




Researcher biases and theoretical 
positioning were not addressed. Few 
records of discordant reports were 
included. 
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process followed till 
completion. 
Siegel et al. 
(1999) 
 
USA N= 48 men, 19 women 
Age=50-69 
Sexual orientation:/ 





community based health 
and social organizations, 
advocacy groups and 
clinics, Urban 
Time since diagnosis: 
range from 1 month to 12 
years, x̄= 6  years 
Disease progression: 










sampling was adopted. 
Recruitment took place 
across a variety of HIV 
specialist centres across 
New York City. Data 
collection took place 
from 1996 to 1997. 
Semi-structured 
interviews were carried 
over two meetings. 
Two members of the 
team carried out a 
thematic analysis of 
interview 
transcriptions. 
 Ambiguity /confusion 
about many common 
symptoms were frequent 
issues for older people 
LWHIV. The study found a 
tendency for participants to 
normalize symptoms – 
hypothesizing this was a 
form of emotional coping. 
HIV poses an existential 
threat, and patients were 
caught between a tension to 
seek more information and 
to take informed health-
promoting actions and the 
need to believe they are 
healthy. Some participants 
were found to prefer this 
ambiguity especially if 
symptom cause might be a 
sign of illness progression. 
On the other hand authors 
argued that the swifter use 
of health services was 
prompted by a desire to 
resolve uncertainty. 
Strengths: Use of design was 
justified by authors. Recruitment 
and data collection procedures were 




Weaknesses:  There was no clear 
statement of the aim of the study. 
Two coders were employed but 
there was no consideration of how 
bias was reduced, nor explanation of 
how categories and themes were 
derived. Thereby impacting on 
overall credibility of the results. 
Brashers et al. 
(2000) 
 
USA N= 29 men, 4 women 
Age x̄ = 37.1 
Sexual orientation: >gay 




Clinical trial Unit 
Disease progression: 21 








Data were collected 
from six focus groups. 
Two researchers 
present where one 
moderated and the other 
 Danger appraisal appeared 




Appraisal of Chronic 
Illness 
Managing information. 
Strengths: Aim and thorough 
rational for design and methodology 
were given. An interview schedule 
was provided giving details of 
interview procedure. Detailed 
explanation of coding procedures 
were outlined. Coding reliability 
was calculated and reported (Cohens 
K=.96). Study results were shared 
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recorded speaking 
order. Open ended 
questions were asked to 
elicit accounts of 
uncertainty. Coding and 
development of 
categories was carried 
out by 6 researchers. 
Results were reported 
to participants to 
receive feedback. 
Weaknesses: In spite of rigor of 
analysis reporting and measures 
adopted to reduce bias, researcher -
participant relationship and potential 





USA N= 25 women 
Age x̄ = 30 
Sexual orientation:/ 




Sampling location: HIV 
pedriatic clinic, Urban 


























For the seropositive women 
who participated in this 
study, uncertainty about 
their HIV was found to 
mediate the relationship 
between health care 
practitioner support and 
parental uncertainty.  
 
Strengths: Aims, methods and 
analysis are well described and 
appropriate.  
  
Weaknesses: The authors of this 
study assume causality though the 
study’s design does not allow for 
this to be inferred. Sample size is 
small and results are difficult to 
generalise to wider population.   
 




USA N= 36 men, 2 women 
















records of telephone 
 Participants described three 
levels of fever rated 
according to level of threat. 
The most threatening were 
the ones participants 
associated to AIDS. 
Participants coping 
strategies were related to 
uncertainty management – 
Strengths: Clear aims of the study 
stated. Detailed description of 
design, context and procedure of 
data recording. 
 
Weaknesses: conversations were not 
audio recorded and transcribed. This 
may have lead to bias through the 
recording of the conversations, in 
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Disease progression: 
diagnosed with AIDS 
conversations with 
patients focusing on 
experiences of fever 
episodes. Telephone 
conversations took 
place in 1996. Data 
saturation was tested by 
testing themes against 
new interviews with 
two participants. 
i.e. participants seemed to 
prefer maintaining 
uncertainty (e.g. thinking 
“maybe is it is just a light 
fever”) and not take 
proactive action (e.g. 
temperature monitoring). 
the type of questions asked by 
different nurses. The authors don’t 
discuss bias in the study. Little 
demographic information is 
available making it difficult to know 
whose voice is being represented. 
Analysis was not described in detail. 
No evidence shared to illustrate 
process leading from categories to 
themes. Data saturation was 
discussed but not exhaustively. 
Brashers et al. 
(2003) 
 
USA N= 29 men, 4 women 
Age x̄ = 37.1 
Sexual orientation: >gay 




Clinical trial Unit 
Time since diagnosis: 
x̄=4.9 years 
Disease progression: 






techniques” were used 
to analyse interview 
transcripts. Data was 
collected from six focus 
groups. Two 
researchers present 
where one moderated 
and the other recorded 
speaking order. Open 
ended questions were 
asked to elicit accounts 
of uncertainty. Coding 
and development of 
categories was carried 
out 6 researchers. 
Results were reported 
to participants to 
receive feedback. 
 
 Several sources of 
uncertainty were identified: 
ambiguous symptom 
patterns, illness 
progression and prognosis, 
financial implications, 
HIV-stigma and disclosure 
of diagnosis. 
Strengths: Aim and thorough 
rational for design and methodology 
were given. An interview schedule 
was provided giving details of 
interview procedure. Detailed 
explanation of coding procedures 
were outlined. Coding reliability 
was calculated and reported (Cohens 
K=.96). Study results were shared 
with participants and feedback was 
sought.  
 
Weaknesses: In spite of rigor of 
analysis reporting and measures 
adopted to reduce bias, researcher -
participant relationship and potential 












 The major theme emerging 
from the analysis was the 
experience of 
unpredictability of illness 
trajectory. Participants 
Strengths: The author addresses 
issues of ethics and confidentiality 
while considering the importance of 
having the voice of PLWHIV 
represented. There is some 
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Sampling: purposive 
sampling 
Sampling location: HIV 
Clinic 





Data collection took 
place in participants 
homes.  Participants’ 
views were obtained 
through semi-structured 




periods of being very ill 
alternated with period of 
recovery resulting in a 
“roller coaster” ride effect. 
consideration of the impact of 
researcher-participant relationship 
bias. Feedback about the results was 
received from participants.  
 
 
Weaknesses: Information was 
lacking about sampling process. 
Analytical bias was addressed via 
the aid of self-reflective diaries. The 
analysis only involved one 
researcher. The sample is small and 
not representative. 
Brashers et al. 
(2004) 
 
USA N= 29 men, 4 women 
Age x̄ = 37.1 
Sexual orientation: >gay 




Clinical trial Unit 
Time since diagnosis: 
x̄=4.9 years 
Disease progression: 








data was collected from 
six focus groups. Two 
researchers present 
where one moderated 
and the other recorded 
speaking order. Open 
ended questions were 
asked to elicit accounts 
of uncertainty. 
“Constant comparative 
techniques” were used 
to analyse interview 
transcripts. Coding and 
development of 
categories was carried 
out by two researchers. 
 
 
 The study elucidated some 
of the processes that link 
illness uncertainty to social 
support – specifically how 
social support may help or 
may not help  manage 
illness uncertainty. 
 
The analysis also revealed 
costs and dilemmas 
associated to accessing 
social support, which can 
bring added uncertainties to 
PLWHIV. The paper 
reports strategies identified 
in managing these costs and 
dilemmas: developing 




unhelpful social situations, 
selection of support person, 
maintaining boundaries. 
Strengths: Aim and thorough 
rational for design and methodology 
were given. An interview schedule 
was provided giving details of 
interview procedure. Detailed 
explanation of coding procedures 
were outlined. Coding reliability 
was calculated and reported (Cohens 
K=.96). Study results were shared 
with participants and feedback was 
sought.  
 
Weaknesses: In spite of rigor of 
analysis reporting and measures 
adopted to reduce bias, researcher -
participant relationship and potential 
influence were not explicitly 
discussed. 
Davis et al. 
(2006) 
UK N= 20 men 
Age = 28-55 
Qualitative cross 
sectional 
 Uncertainties related to 
HIV infection have not 
Strengths: Detailed description of 
interviews, data collection and 
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 Sexual orientation: gay 





Sampling location:  HIV 
Clinic, Urban 
Time since diagnosis: 9 









between 2001 and 
2002. Interviews were 
transcribed. Constant 
comparison was used to 
generate themes. 
been erased by HAART. 
The concept of 
“technological horizon” 
surfaced to describe a way 




spoke of delaying HAART 
and managing change in a 
way that maximizes 
benefits to them. 
sampling provided. Ethical issues 
discussed in the paper. The study 
identified participants that were 
diagnosed pre-HAART. 
 
Weaknesses: Little description of 
analytical process was provided. 
Analytical bias was discussed 
briefly in the paper and no reflexive 
account of researcher-participant 
relationship was given. There is 
little mention of researchers seeking 
to verify credibility of the findings. 
The study does not include women. 
Frain et al. 
(2008) 
 
USA N= 110 men, 15 women 
Age= 
21-50 






flyers, personal ads 














Uncertainty and optimism 
accounted for 61% of 
variance in the model that 
predicted participant 
quality of life. Family 
variables added in on the 
third step to hierarchical 
regression explained only 
1% of variance. 
Strength: the study integrated 
subjective definitions of family, thus 
allowing the exploration of impacts 
of family support on QoL, in across 
different understandings of family. 
 
Weakness: 
 Beta values of single predictors 
were not reported. This means that 
the individual contribution/ effect 
sizes of the predictors could not be 
investigated. 
Sample was recruited online only 





USA N= 21 women 
Age= 21-50 
Sexual orientation: / 
Ethnicity: 60% Ethnic 
minority, White 40% 
Sampling: Convenience 
sampling 
Sampling location: HIV 
pedriatic clinic, Urban 








Took place from 2004 
to 2007. Six measuring 
points starting at third 
trimester of pregnancy. 











Negative HIV test result of 
child resulted in decrease of 
Parental uncertainty. A 
strong negative correlation 
was found between of 
parental illness uncertainty 
and social support and a 
strong positive correlation 
with social network 
conflict.  
 




Weaknesses: The aim of the study 
was somewhat unclear. No 
hypothesis put forward though 
theory and past research would have 
enabled this. Small sample size – 
results are not generalizable. Two of 
the women did not know they were 
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taken 4 weeks after the 
infant’s HIV viral test at 
18 months of age. 
HIV positive at beginning of 
pregnancy potentially bringing some 
confounding effects.  
. 













Sampling location: HIV 
Clinic, Urban 







42 “in depth 
interviews” were 
carried out and 4 sex 
and residence specific 
focus groups were 
conducted exploring 
factors influencing HIV 
clinic attendance. Data 
was transcribed and 
coded. 
 
 Uncertainty about the 
veracity of HIV diagnosis 
(competing illness 
explanations e.g. virus vs. 
being bewitched vs. god 
has healed me) impacted 
attendance to clinic and 
treatment adherence. A 
desire to seek certainty by 
monitoring disease 
progression was associated 
with adherence/attendance. 
Strengths: study gives very clear 
description of setting and how data 
was collected. Data was 
independently coded by a second 
researcher and compared. Sample 
was relatively large covered persons 
living in rural and urbanized areas. 
 

















Sampling location: HIV 
Clinic, Urban 










 In context of fragile 
delivery of treatment, 
perceived poor quality of 
information exacerbated 
sense of uncertainty. Three 
strategies identified in 
managing uncertainty: 
fostering network and 
resources to ensure 
optimum access to 
information and treatment. 
To ration contact with 
other PLWHIV to avoid 
alarming rumours. The 
third strategy was to stop 
taking treatment as 
precarity of situation was 
seen as more risk than gain. 
Strengths 
Large sample recruited through 
networks and different 
governmental and non-
governmental agencies, thus 
increasing representability. 
 
Translators were used to aid 
inclusion of minority participants. A 
sample of translations was cross 
checked to assert accuracy. 
 
Weaknesses 
Analytical bias was addressed but 
not in detail. Credibility of the 
findings was not discussed. 
Limited sample demographics 
provided. 
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Campbell et al. 
(2010) 
 









Sampling location: HIV 
Clinic, Urban 








Telephone or in person 
interviews took place. 
Participants were asked 
4 questions related to 
their experiences in an 
HIV management 
group for youths. 
Responses were 
transcribed and 
analysed by two 
researchers. Themes 
were reviewed with 
interviewers. 
 Helpful experiences were: 
“being with others who are 
the same is helpful”; 
Discussing disclosure 
(voluntary or not), 
discussing pros and cons of 
medication. And 
uncertainty in the future 
while being hopeful. 
Strengths: this was the only study 
that reported experiences of 
uncertainty in young people living 
with HIV. Provides some evidence 





Small sample. Little detail of 
interviews were provided. Little 
discussion around bias. 
Perrett et al. 
(2013) 
 























participant carried out 
two interviews at 6 
months apart to gain 
understanding of 
adaptation. 
Transcriptions of audio 
records were made and 
coded by two 
researchers 
 “Negotiating uncertainty” 
emerged as the core 
concept. Main category 
consists of adaptation to 
uncertainty following 
diagnosis through: finding 
strength through hope, gain 
control of the virus, seizing 
opportunities. Relativizing 
ones illness to others, 
planning for the future, and 
“adapting to the fact that 
there is nothing to adapt to” 
allowing one to make plans 
for the future. 
Strengths: Thorough description of 
coding methods. Two interviews 
carried out at 6 months apart to 
investigate adjustment trajectory. 
 
Weaknesses: Evidence from 
transcripts was sometimes missing. 
Only men were included in the study 
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Perrett et al. 
(2013) 
 
UK N= 39 men, 16 women 
Age= >50 
Sexual orientation:/ 






HIV Clinic, Urban 








Data gathered through 
focus groups with the 
first sample were 
analysed with the aim 
of producing topic 
guides for life-history 




interviews posed open 
ended questions. 
A mixture of inductive 
and deductive thematic 
analysis was used to 
analyse the interview 
data. 
 Aging with HIV as 
“unchartered territory” was 
a major theme in the 
interviews and the concerns 
surrounding symptom 
identification (is it aging or 
HIV?), premature mortality 
and health practices also 
emerged. There were also 
concerns of the impacts 
aging with HIV would have 
on the participant’s 
children. Interviews with 
women also raised to 
attention themes which 
were specific to sex such 
aging with HIV and the 
menopause. 
Strengths: the study relies on a two-
stage process which based on 
different stakeholders – potentially 
broadening thematic scope and 
informing interview content. The 
sample employed was large and in 
some respects representative of 




The study does not specify how 
many coders were involved in 
analysis and what measures were 
introduced to minimise bias. 
Solomon et al. 
(2014) 
 
Canada N= 29 men, 20 women 
Age= >50 
Sexual orientation:/ 




Sampling location: HIV 
Clinic, Urban 









interviews took place 
face to face or over the 
telephone by a research 




analysis was carried out 
till saturation. 
 Uncertainties related to 
aging were: uncertainty 
around the source of their 
health problem (i.e. is it 
HIV or aging?); uncertainty 
around health care 
professional knowledge of 
aging with uncertainty 
given the historically new 
phenomenon; financial 
uncertainty related to the 
fact many had not expected 
to live a long life; 
difficulties in transitioning 
into a pension; 
uncertainties around who 
would care for them in the 
 
Strengths: three raters were adopted 
for coding. Excerpts were used 
frequently to demonstrate coherence 
of themes and exceptions were also 
integrated in the results. 
 
Weaknesses: mean age was 56. Bias 
was not explicitly discussed in the 
study. 
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future; uncertainty around 
long term housing; and 
uncertainty around the 
episodic nature of HIV 
related health events. 
Sajjadi et al. 
(2015) 
 
Iran N= 49 men, 31 women 





Sampling location: HIV 
Clinic, Urban 










Scale – Adult 
version. 
 
The study showed that 
individuals that scored 
higher on perceived social 
support scored lower on 
illness uncertainty. The 
model showed that a .26 
unit increase in perceived 
social support predicted 1 
unit drop in illness 
uncertainty. 
Strenght: The study provides some 
cross-cultural validation for the 
relationship between social support 
and illness uncertainty in PLWHIV. 
 
Weaknesses: 
Small opportunity sample is not 











Sampling location: Local 
AIDS services, Urban 















coding was based on 
knowledge of stigma, 
uncertainty, and 
resilience. These were 
used to identify central 
themes of the study. 
Peer-debriefings were 
conducted between 
authors to discuss 
interpretation and 
consensus of themes 
 
 Themes of uncertainty in 
older adults arose around 
unexpected survival, 
symptom interpretation and 
medical uncertainty. Some 
of the stories in the study 
brought to light some of the 
ways in which uncertainty 
and stigma can contribute 
to poor mental health. 
Strength: 
The study focuses on the 
experiences of older adults. 
 
Weaknesses: 
- only one researcher coded the 
recordings. 
- Theoretically driven coding could 
be argued to have increased bias. 
- Sample is unlikely to be 
representative due to size and 
recruitment. 
- biased was not addressed. 
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Brashers et al. 
(2017) 
 
USA N= 83 men, 14 women 
Age x̄ = 36.25 





Sampling location: AIDS 
Clinical trial unit 
Time since diagnosis: 














experimental group or 
waiting-list control 
group. Treatment 
consisted of a peer 
educator delivering 
skill-development tools 







 The intervention led to a 
steeper decline in 
uncertainty and depression. 
It is argued that tactical 
communication skills e.g. 
such as in disclosure of 
HIV status helped 




Pre-test post-test design gives some 
support to causality. 
 
Weaknesses 
Participants are mostly men and 
were recruited from the one 
location, thus not representative. 
 
Social support construct was not a 
validated measure. 
 
Effect sizes were not reported. 
 
How much of the effect was due to 
peer-support delivery – and how 
much was it due to skills training is 
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Appendix E. Thematic table with selection of participant’s quotes 
 
Organizing 
theme Basic theme Sub-theme Participant quote 






of symptoms  
 
This morning when I was getting up ... I wasn’t that sure footed. Is it age or is it 
AIDS? 
(Solomon et al., 2014) 
 
 Disease progression  
 
I was on a protease for three months and my viral load was near undetectable and 
then my CD4 counts did nothing they just stay around 60, 70, and uh, the doctor 
calls me up and says, `you know your viral load is almost undetectable’ . Two 
days later I’m in the hospital with pneumonia. So you spend two days celebrating 
and then you think like `well, what’ s up with this?’ You know, `what is going 
on? 












Now my treatment is available at the pharmacy but I don’t know for how long 







I’m really just trying to deal with today because I don’t know what the long-term 
effects of all these new treatments are going to be yet. 
(Brashers et al., 1999) 
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Personal Financial  
Economically [growing older] is a bit scary because .. . in a certain sense ... , I 
haven’t put away [any money] and I haven’t been able to put away. You know, 
choices you make and then the realities that affect those choices 
(Solomon et al., 2014) 
 
I’ve done all kinds of things planning on my death. And, if I don’t die, I owe an 
awful lot of people an awful lot of money  







Then sometimes I want to say “but wait a minute, I am here and I am positive 
too. Don’t forget me”. Because sometimes they do treat me as though I am just 
OK. Which is fine, I don’t want to be treated like an invalid. 
(Brashers et al., 2003) 
 
 
 Professional identity  
I was always independent. Now, all of a sudden, I’m asked to learn this. This is 
devastating. I don’ t like being on welfare, going and collecting food stamps, you 
know. I’ve been on disability, on SSDI, for a year. And yeah, I want to get back 
into nursing.  
 
What is going to happen if I do go back to work? Am I going to get so stressed 
out I’m going to end up in the hospital again? 
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(Brashers et al., 1999) 
 
Stigma and 
disclosure   
I certainly feel restricted talking about both issues … but if I am going to open 
up about anything, I’m probably going to open up about my HIV status more than 
my mental health status. I find, for me, I have self-stigmatized, I guess, on mental 
health more than HIV 







Global theme: managing illness uncertainty 
 
Seeking 
information   
I’m well aware of the risks that are involved . . . to keep on top of those risks I 
have myself monitored more often and make sure I know the results and what 
have you. 
 
(Davis et al., 2006) 






I didn't want to find out I had AIDS. Even though I kind of figured I did, I didn't 
want to know. I wanted to live a normal life for as long as I could. 
(Weitz, 1989) 
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Accepting 
uncertainty   
 What doesn’t kill you, makes you stronger’ sort o’ thing. You know so what I’m 
saying there is that if you don’t have any control over it, why bother worrying 
about it? 
 
Time is the factor on a lot of HIV people. And if anything, time gives you hope 
as well, believe it or not . . . I deal with that bridge when I cross it’  
 
(Davis et al., 2006) 
 
I look forward. I feel insecure but I am OK with it 








So I thought, “if all else fails, go back to what you know.” So I went back to what 
I knew. And I called my parents on the phone and I said “I have 64 T cells.” Mom 
says “well how many are you supposed to have?” And I said, “Thousands!” She 
says “quit your job and come home.” You know, she said “you and Peter pack up 
and you just come home.” So I called my boss and I said “I quit.” 
 
(Brashers et al., 2004) 
 
I know that I have somewhere to talk about things, although I can talk to my aunt, 
it is good to talk to people my age as well and be open about things. I feel better 
about managing and looking after myself in the future, but know that it will 
depend on the situation 
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Appendix F. Patient information sheet 
 
Salomons Centre for Applied Psychology 
 
Exploring the relationships between experiences of 
discrimination, illness-related uncertainty and quality of life 
in people living with HIV 
 
 
Who are we? 
My name is Riccardo Zito and I am a Doctoral Candidate in Clinical Psychology at the Salomons 
Institute for Applied Psychology in the United Kingdom. This study is supervised by Dr Stuart 
Gibson (Barts Health NHS Trust) and Prof Margie Callanan (Salomons, Canterbury Christ Church 
University).  
I would like to invite you to take part in a study which will form part of my doctoral thesis. 
What is the study about? 
 
Results from research suggest that people living with HIV can express various degrees of uncertainty 
relating to life with the disease. This study will explore how general wellbeing in living with HIV is related 
to such ‘illness uncertainty’ and the experience of discrimination. This could be important in helping to 
identify people who are more vulnerable to the effects of illness uncertainty so we can develop better 
ways of supporting them in the future.  
Who can participate? 
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You can participate in this study if you: 
- are 18 years of age or older; 
- were diagnosed with HIV at least more than one year ago; 
- have disclosed your HIV status to at least one person who is not a health care professional; 
- are living in one of the following countries: Australia, Canada, Ireland, New Zealand, United 
States, United Kingdom; 
- are not acquainted with the researchers conducting this study. 
Unfortunately, this study does not have resources to translate the questionnaires into different languages. 
As a result, participants will need to be able to read English. 
What will happen to me if I take part? 
Participation in this study is anonymous.  
You will be asked to provide some demographic and other personal non-identifiable information. This will 
only take about one minute.  
If you meet the participation criteria, you will be asked to respond to a set of questionnaires exploring your 
experiences of illness related uncertainty, discrimination, general wellbeing and social support.  
Participating typically takes between 15 to 25 minutes. We will not need to contact you again once you 
have completed the survey.  
 
Are there any benefits in taking part? 
Unfortunately, we do not have the resources to pay participants for their time.  
What are the risks of taking part? 
There are no known risks for you in participating in the survey. Though some of the questions may lead 
you to remember some unpleasant experiences in your life, answering them is not expected to cause you 
any harm or distress.  
Online related activity always poses risk of a security breach. Although this is highly unlikely, it cannot be 
ruled out. When participating in this survey, it is important for you to feel safe. Please chose a private 
place for you to read and respond to questions of a personal nature. When filling out the survey online, it 
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is also advisable to make sure you are using a secure internet connection (e.g. your own home internet 
connection).  
What will happen to the data I submit? 
Some parts of the anonymized data collected for this study will be seen by authorized persons from 
Canterbury Christ Church University. But this will only take place when the results are being analysed by 
statistical consultants.  
Your anonymous answers will be saved securely for 10 years. After this time, all information will be 
disposed of securely. During this time all precautions will be taken to keep the information you have 
submitted safe. 
You can always decide to stop being a part of this study while you are completing the survey. However, 
as the contributions will be anonymous, it is not possible to withdraw once you complete and submit your 
survey responses. 
 
What will happen to the results of the research study? 
The results of the survey will be presented as part of a Doctorate thesis at Canterbury Christ Church 
University. The findings will also be published in a scientific journal, and possibly presented at academic 
conferences.  
Who has reviewed the study?  
This research is organized and funded by Canterbury Christ Church University and was reviewed and 
authorized by Salomons Institute for Applied Psychology Ethics Panel. The purpose of the panel is to 
safeguard the interests of the individuals who accept to take part in  research projects such as this one.  
Further information and contact details 
If you encounter any problems or you would like to speak to me and find out more about the research we 
are conducting, feel free to contact me by email: 
 
Riccardo Zito, Trainee Clinical Psychologist 
EMAIL: r.zito17@canterbury.ac.uk 
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Alternatively, if you have any complaints or concerns you can contact the head of research at the 
Salomons Institute for Applied Psychology: 
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Appendix G. Patient consent form 
 
Salomons Centre for Applied Psychology 
 
Title of Project: Exploring the relationships between experiences of 
discrimination, illness related uncertainty and quality of life in people 
living with HIV 
 
Name of Researcher: Riccardo Zito 
I confirm that I have read the information sheet for this study.  
I understand that my participation is voluntary and that I may withdraw from 
the research at any time up until the submission of the questionnaire. 
My data will be kept on a secure computer for the duration of the analysis 
and stored on an encrypted DVD in a locked cabinet on university grounds. 
The data will be deleted 10 years after the appearance of any related 
publication. 
I give permission for the researchers of this study to have access to these 
data and to collect, store, analyze and publish information obtained from my 
participation in this study. 
I understand that if I decide to submit my email addresses it will be kept 
separate from the research data I will submit, and that it will be kept 
confidential. The email address will only be used for the purpose of receiving 
the outcomes of the study. 
By completing and submitting the questionnaire I am giving my consent for 
my data to be used for the outlined purposes of the present study. All 
questions that I have about the research have been satisfactorily answered.  
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Appendix H. Demographic items and constructs 











































 - 123 - 
Appendix I. Ethics board approval  
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Appendix K. Scatter plot of standardized residual against standardised predicted value for 
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Appendix L. Scatter plot of standardized residual against standardised predicted value for 
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If you feel that you would like to talk to someone about how you feel or about any troubling 












If you would like to speak to someone about the medical and psychological implications of being 




or call: 1-800-263-1638 
 












or access the Health Service Executive (HSE) HIV and sexual health Helpline on: 1800 459 459  
 
More HSE contact details are available at the following link: 
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https://www.hse.ie/eng/services/list/5/addiction/drugshivhelpline/hiv-and-sexual-health-helpline/ 
 











If you feel you need to speak to someone about how you feel or about any troubling experiences 












If you feel you need to speak to someone about how you feel or about any troubling experiences 






The following link provides a list of hotlines redacted by the Ryan White and Global HIV/AIDS 




The following link takes you to a governmental search engine which can search resources and HIV 
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If you would like to get general information on mental health and locate mental health services in 
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Appendix O. End of study summary sent to the Salomons Ethics Committee 
Dear members of the Salomons Ethics Committee, 
I am writing to inform you that I have completed the empirical research project approved by you 
on 30 October 2019. A brief summary of the research findings follows below. 
 
Study title: The social environment, illness related uncertainty and quality of life of people 
living with HIV 
Study background 
Uncertainty related to illness has been shown to be linked to the mental and physical health of 
individuals living with chronic conditions, such as HIV. Theory and research both suggest that 
social support and adverse social experiences can greatly influence the level of illness uncertainty 
individuals experience. Positive social contact has been shown to be instrumental in managing 
illness related uncertainty. This is because interacting with supportive others can help individuals 
make sense of their illness, but also because supportive others can provide forms of material 
support that can help alleviate uncertainty. However, because people living with HIV are likely to 
experience different forms of discrimination, not only related to HIV-stigma (e.g. 
trans/homophobia, racism, ageism etc.),  it is possible that they may at times find it difficult to 
access social support. This raises the question of whether stigma and discrimination may 
exacerbate the level of illness uncertainty individuals experience. It was the aim of this study to 
explore how experiences of discrimination and social support may be related to illness uncertainty 
of people living with HIV, and to explore how these, in turn, relate to their quality of life.  
Results 
One-hundred and twenty-five people living with HIV completed the online questionnaire. The 
analysis showed that participants who reported being subjected to multiple forms of discrimination 
or who reported experiencing discrimination more frequently, also experienced significantly 
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higher levels of illness uncertainty. In turn, those experiencing higher levels of uncertainty also 
reported lower levels of quality of life. As expected, participants reporting more social support 
reported experiencing less illness related uncertainty and better quality of life. 
What do these results mean? 
The data analysis reproduced results, similar to previous studies investigating uncertainty in other 
chronic conditions, such as the fact that people experiencing better social support tend to also 
experience less illness uncertainty and report higher levels of quality of life. In addition, this study 
presented new evidence suggesting that experiences of stigma and discrimination could potentially 
lead individuals to experience higher levels of illness uncertainty. If this were the case, the question 
of how stigma and discrimination might lead to increased experiences of illness uncertainty could 
be important in the way support is provided. It could be that people that are confronted with 
multiple forms of stigma have less opportunities to access social contexts that feel safe, and as a 
consequence, experience more illness uncertainty. An alternative explanation could be that 
because stigma and discrimination can lead people to experience higher levels of anxiety this may 
in turn lead individuals to focus more on worrisome experiences of illness, thereby increasing a 
sense of insecurity related to the illness. These hypothetical explanations are not mutually 
exclusive but have different implications in terms of the way effective support can be provided. In 
summary, this study brings forth evidence that people living with HIV that experience multiple 
forms of stigma and higher levels of discrimination are more likely to experience higher levels of 
illness uncertainty – this is also likely to impact their quality of life. Future research should focus 
on identifying who is more at risk and how support can be better tailored to individual needs. 
 
